{
  "meta": {
    "title": "211_Medicine_Aiims_2017",
    "url": "https://brainandscalpel.vercel.app/211-medicine-aiims-2017-dd4c8ae6.html",
    "scrapedAt": "2025-11-30T12:56:57.933Z"
  },
  "questions": [
    {
      "text": "An 18-year-old girl with the diagnosis of acute promyelocytic leukemia was treated medically. She developed fever and tachypnea and a chest X-ray showed pulmonary infiltrates. What drug should she be given next?",
      "choices": [
        {
          "id": 1,
          "text": "Cytarabine"
        },
        {
          "id": 2,
          "text": "Dexamethasone"
        },
        {
          "id": 3,
          "text": "Doxorubicin"
        },
        {
          "id": 4,
          "text": "Methotrexate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario describes a patient of <strong>APL </strong>(acute promyelocytic leukemia) developing <strong>fever, tachypnea</strong>, and<strong> pulmonary infiltrates</strong> while <strong>on medical treatment</strong>. This is suggestive of <strong>APL differentiation syndrome</strong>, an <strong>adverse effect </strong>of <strong>all-trans-retinoic acid (ATRA)</strong>. The management involves glucocorticoids like <strong>dexamethasone</strong>.&nbsp;</p>\n<p>Along with <strong>glucocorticoids</strong>, the other management of APL differentiation syndrome includes <strong>chemotherapy </strong>for <strong>cytoreduction </strong>and <strong>supportive measures</strong>. In <strong>severe </strong>cases,<strong> temporary discontinuation of ATRA</strong> is necessary.</p>\n<p><strong>ATRA</strong> is an oral drug that induces the <strong>differentiation</strong> of leukemic cells bearing the <strong>t(15;17) </strong>chromosomal translocation. While ATRA reduces the incidence of <strong>DIC</strong> associated with <strong>cytarabine</strong> and <strong>daunorubicin</strong> used earlier in APL, it can cause <strong>APL differentiation syndrome</strong> due to the <strong>adhesion </strong>of differentiated neoplastic cells to the <strong>pulmonary vasculature endothelium</strong>.</p>\n<p>In <strong>low-risk APL </strong>patients with a low leukocyte count at presentation, a combination of <strong>ATRA </strong>and <strong>arsenic trioxide (ATO)</strong> has been found to be superior and is the current standard of care.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1143",
      "difficulty": "easy"
    },
    {
      "text": "The definition of fever of unknown origin (FUO) includes all of the following, except:",
      "choices": [
        {
          "id": 1,
          "text": "Undiagnosed after one week of investigation"
        },
        {
          "id": 2,
          "text": "Immuno compromised status should be ruled out"
        },
        {
          "id": 3,
          "text": "Temperature more than 38.3 C"
        },
        {
          "id": 4,
          "text": "Fever persisting for more than 3 weeks"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The current definition of <strong>fever of unknown origin (FUO)</strong> does <strong>not include</strong> undiagnosed after one week of investigation. The criterion \"diagnosis uncertain, after 1 week of evaluation\" which was previously a part of the definition has been removed.</p>\n<p><strong>FUO </strong>is currently defined as:</p>\n<ul>\n<li aria-level=\"1\"><strong>Fever ≥38.3°C</strong> (≥101°F) on at least <strong>two occasions </strong></li>\n<li aria-level=\"1\">Duration of <strong>≥3 weeks</strong></li>\n<li aria-level=\"1\"><strong>No known immunocompromised state</strong></li>\n<li aria-level=\"1\"><strong>Diagnosis is uncertain </strong><span>after thorough history-taking, physical examination, and obligatory investigations.</span></li>\n</ul>\n<p><strong>Inflammation of Unknown Origin (IUO)</strong> is closely related to FUO. It has the same definition, <strong>except for the body temperature </strong>criterion. IUO is characterized by elevated inflammatory parameters (such as CRP or ESR) on multiple occasions for at least three weeks in an immunocompetent patient with normal body temperature. The causes and workups for IUO are similar to those for FUO.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1144",
      "difficulty": "medium"
    },
    {
      "text": "A 43-year-old patient presented with spikes of fever and difficulty in breathing. Transesophageal echo revealed vegetations in the heart. The culture was positive for Burkholderia cepacia. Which of the following is the first line of management?",
      "choices": [
        {
          "id": 1,
          "text": "Aminoglycosides and colistin"
        },
        {
          "id": 2,
          "text": "Cotrimoxazole with 3rd generation cephalosporin"
        },
        {
          "id": 3,
          "text": "Cefepime and tigecycline"
        },
        {
          "id": 4,
          "text": "Carbepenams and 3rd generation cephalosporins"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The first-line agents used in the management of<strong> <em>Burkholderia cepacia</em></strong> complex<em><strong> </strong></em>(BCC)<em><strong> </strong></em>infections are trimethoprim-sulfamethoxazole (<strong>cotrimoxazole</strong>), meropenem, minocycline, and <strong>ceftazidime</strong> (3<sup>rd</sup> generation cephalosporin).</p>\n<p>Other options:</p>\n<p>Option A<strong>:</strong> <em>Burkholderia</em> species are <strong>intrinsically resistant to aminoglycosides and polymyxins</strong>.</p>\n<p>Option C: Tigecycline is less effective in the case of <em>Burkholderia</em> infections.</p>\n<p>Option D: Carbapenems and 3<sup>rd</sup> generation cephalosporins have the same mechanism of action and compete for the same binding site. Hence, it is not a rational drug combination. </p>\n<p>BCC is a group of bacteria known for causing <strong>severe respiratory distress</strong> and <strong>septicemia</strong>, particularly in patients with <strong>cystic fibrosis</strong> (CF). BCC organisms are also found in <strong>ICU</strong> patients and individuals with <strong>chronic granulomatous disease</strong>, leading to lung disease. BCC colonization in CF patients <strong>prior to</strong> <strong>lung transplantation</strong> increases the risk of death during the early transplant period.</p><hr><h3>Related Pearl: List of intrinsic drug resistance in bacteria</h3><p> </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Organism</strong></td>\n<td><strong>Intrinsic Drug Resistance</strong></td>\n</tr>\n<tr>\n<td>\n<p>Acinetobacter baumanii</p>\n</td>\n<td>\n<p>Ampicillin,Amoxicillin,Ertapenem,Trimethoprim,Chloramphenicol</p>\n</td>\n</tr>\n<tr>\n<td>Pseudomonas aeruginosa</td>\n<td>Ampicillin,Amoxicillin-Clavulanate,Ceftriaxone,Ertapenem,Tetracyclines/Tigecyclines, Trimethoprim-sulfamethoxazole,Chloramphenicol</td>\n</tr>\n<tr>\n<td>Bacteroides fragilis</td>\n<td>Aminoglycosides,Ampicillin</td>\n</tr>\n<tr>\n<td>Gram positive bacteria</td>\n<td>Aztreonam</td>\n</tr>\n<tr>\n<td>Staphylococcus saprophyticus </td>\n<td>Novobiocin</td>\n</tr>\n<tr>\n<td>Enterococcus fecalis/fecium</td>\n<td>Cephalosporins,Aminoglycosides,Clindamycin,Polymyxin B</td>\n</tr>\n<tr>\n<td>Clostridium species </td>\n<td>Aminoglycosides</td>\n</tr>\n<tr>\n<td>Gram negative bacteria</td>\n<td>Vancomycin</td>\n</tr>\n<tr>\n<td>Klebsiella pneumoniae</td>\n<td>Ampicillin</td>\n</tr>\n<tr>\n<td>Enterobacter</td>\n<td>Ampicillin</td>\n</tr>\n<tr>\n<td>Aerobic bacteria</td>\n<td>Metronidazole</td>\n</tr>\n<tr>\n<td>Lactobacillus &amp; Leuconostoc</td>\n<td>Vancomycin</td>\n</tr>\n<tr>\n<td>Burkholderia</td>\n<td>Polymyxins and aminoglycosides</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong> </strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1146",
      "difficulty": "medium"
    },
    {
      "text": "The radio-iodine uptake scan of a patient evaluated for swelling of the thyroid is shown below. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Hypersecreting adenoma"
        },
        {
          "id": 2,
          "text": "Papillary Carcinoma thyroid"
        },
        {
          "id": 3,
          "text": "Graves disease"
        },
        {
          "id": 4,
          "text": "Lateral aberrant thyroid"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image showing localized overactivity (increased uptake) in the left lobe of the thyroid i.e., <strong>hot nodule</strong>, with suppression of the remainder of the gland, is suggestive of a <strong>hypersecreting adenoma</strong>.</p>\n<p>Other options: </p>\n<p>Option B: The likelihood of <strong>malignancies</strong> like papillary Carcinoma thyroid is <strong>low</strong> (5%) in the case of a <strong>hot nodule</strong>.</p>\n<p>Option C: <strong>Graves disease</strong> shows <strong>diffusely increased uptake</strong> on a thyroid scan.</p>\n<p>Option D: <strong>Lateral aberrant thyroid</strong> presents with swelling of <strong>cervical lymph nodes</strong> and not thyroid. It is due to<strong> skip metastasis</strong> from<strong> papillary thyroid carcinoma </strong>to the ipsilateral cervical lymph nodes.</p>\n<p>The thyroid scan appearance in different conditions is shown in the image below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/446147cae6bd406294d261351cfe7cdfx1280x2916.JPEG\" alt=\"Explanation Image\"><p><strong>Diagnostic isotope</strong> studies, such as 99mTc-pertechnetate and iodine-123, are becoming less common in thyroid imaging because some <strong>warm swellings (5%)</strong> which are actually <strong>malignant</strong> could be <strong>mistaken as benign</strong>. Isotope scanning is most valuable when assessing a <strong>hyperthyroid patient</strong> presenting with a nodule or nodularity in the thyroid. It helps to identify <strong>overactivity in the gland</strong>, which can <strong>differentiate</strong> between a <strong>toxic nodule</strong> that suppresses the rest of the gland and a <strong>toxic multinodular goitre</strong> with multiple areas of increased uptake.</p><hr><h3>Related Pearl: Radioiodine uptake of thyroid gland</h3><p>Radioactive iodine uptake (RAIU) scans are interpreted as follows:</p>\n<ul>\n<li><strong>High</strong> (or normal) radioiodine uptake indicates de-novo synthesis of the hormone. Therefore, there is increased hormone synthesis</li>\n<li><strong>Low</strong> (nearly absent) radioiodine uptake indicates:\n<ul>\n<li>Inflammation and destruction of thyroid tissue with release of the preformed hormone into the circulation</li>\n<li>Extrathyroidal source of thyroid hormone</li>\n</ul>\n</li>\n</ul>\n<p>Conditions with high and low RAIU are given below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>High RAIU</strong></td>\n<td><strong>Low RAIU</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Graves&rsquo; disease</li>\n<li>Toxic multinodular goiter</li>\n<li>Toxic adenoma</li>\n<li>Thyroid cancer</li>\n<li>Hydatidiform mole</li>\n<li>TSH-secreting pituitary adenoma</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Acute phase of Hashimoto&rsquo;s thyroiditis</li>\n<li>Drug-induced&mdash; iodine, amiodarone-induced thyroiditis</li>\n<li>Subacute/ Dequervain thyroiditis</li>\n<li>Radiation thyroiditis</li>\n<li>Metastatic follicular thyroid carcinoma</li>\n<li>Factitious (iatrogenic) thyrotoxicosis</li>\n<li>Struma ovarii (extrathyroid source)</li>\n<li>Hamburger thyrotoxicosis (exogenous source)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/84debe461e9e4ef6a8de25fbe9c71e7fx1280x3027.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d2d0ede29d4d42ce98e2ed30593c890f.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1541",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following diseases primarily involves the marked structure?",
      "choices": [
        {
          "id": 1,
          "text": "Paralysis agitans"
        },
        {
          "id": 2,
          "text": "Depression"
        },
        {
          "id": 3,
          "text": "Alzheimers"
        },
        {
          "id": 4,
          "text": "Huntington chorea"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The structure marked in this transverse section of the brain at the level of superior colliculus is <strong>substantia nigra</strong>. Degeneration of substantia nigra is seen in <strong>Parkinson's disease</strong>, also known as <strong>paralysis agitans</strong>.</p>\n<p><strong>Substantia nigra</strong> is pigmented due to the presence of <strong>neuromelanin</strong> granules, which help in the synthesis of <strong>dopamine</strong>. In Parkinson's disease, there is an <strong>absence/reduced pigmentation</strong> of the substantia nigra.</p>\n<p><strong>Bradykinesia, rigidity</strong>, and <strong>resting tremor</strong> are classic features of Parkinson's disease. Because of motor disability, it is also referred to as paralysis agitans.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Depression</strong> is often a comorbid finding with Parkinson's disease, but is <strong>not</strong> due to damage to the substantia nigra.</p>\n<p>Option C: <strong>Alzheimer&rsquo;s disease</strong> is the most common cause of dementia. It is due to atrophy of the entorhinal cortex, located in the <strong>medial temporal lobe</strong>.</p>\n<p>Option D: <strong>Huntington&rsquo;s chorea</strong> is an autosomal dominant disorder of movement and cognition primarily involving the <strong>striatum</strong> (caudate nucleus and putamen).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5f813fbb8ee5461a8455492a12746f77x600x906.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Abnormal movements</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Movement</strong></td>\n<td><strong>Site</strong></td>\n<td><strong>Description</strong></td>\n<td><strong>Cause</strong></td>\n</tr>\n<tr>\n<td>Intentional tremor</td>\n<td>Cerebellum</td>\n<td>Only on activity&nbsp;</td>\n<td>\n<ul>\n<li>Trauma</li>\n<li>Stroke</li>\n<li>Alcohol</li>\n<li>Drugs</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Resting tremor</td>\n<td>\n<p>Substantia nigra</p>\n<p>Red nucleus</p>\n</td>\n<td>Disappear on movement</td>\n<td>\n<ul>\n<li>&nbsp;Parkinsonism</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hyperkinetic tremor</td>\n<td>Sympathetic overactivity&nbsp;</td>\n<td>Precipitated by emotion , stress</td>\n<td>\n<ul>\n<li>Anxiety&nbsp;</li>\n<li>Hyperthyroidism&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Asterixis</td>\n<td>Cortex</td>\n<td>Inability to sustain a muscle contraction while performing a complex motor movement</td>\n<td>\n<ul>\n<li>Hepatic encephalopathy&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Chorea</td>\n<td>Caudate nucleus and putamen</td>\n<td>&nbsp;Rapid jerky movement</td>\n<td>\n<ul>\n<li>Rheumatic chorea</li>\n<li>Huntington chorea</li>\n<li>Drug induced&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hemibalismus</td>\n<td>Subthalamic nucleus</td>\n<td>Unilateral wild flinging violent movement of large proximal joints</td>\n<td>\n<ul>\n<li>Vascular&gt;degenerative&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Athetosis</td>\n<td>Basal ganglia- Globus Pallidum</td>\n<td>Slow writhing movement involving distal joints</td>\n<td>\n<ul>\n<li>Vascular&nbsp;</li>\n<li>Degenerative&nbsp;</li>\n<li>Infiltrative</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/71be37076f91458cbdb3a43fada1746f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0619",
      "difficulty": "medium"
    },
    {
      "text": "All are components of CURB65 except",
      "choices": [
        {
          "id": 1,
          "text": "Confused state"
        },
        {
          "id": 2,
          "text": "Respiratory rate of > 30 /min"
        },
        {
          "id": 3,
          "text": "Blood urea nitrogen value greater than 7 mmol/L"
        },
        {
          "id": 4,
          "text": "Systolic blood pressure less than 100 mm Hg"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the options, <strong>systolic blood pressure less than 100 mm Hg</strong> (Option D) is <strong>not</strong> a component of <strong>CURB-65</strong>. CURB65 includes blood pressure, <strong>systolic &le;90</strong> mmHg or <strong>diastolic &le;60</strong> mmHg.</p>\n<p><strong>CURB-65</strong> criteria is used to <strong>assess</strong> the <strong>severity of illness</strong> in a case <strong>community-acquired pneumonia</strong>. It includes <strong>confusion</strong> (C), <strong>urea &gt;7</strong> mmol/L (U), <strong>respiratory rate &ge;30/min</strong> (R), blood pressure <strong>systolic &le;90</strong> mmHg or <strong>diastolic &le;60</strong> mmHg (B) and an <strong>age</strong> of <strong>&ge;65</strong> years.</p>\n<p>Pneumonia severity index (PSI) is another index to assess the severity of illness and the risk of mortality in the case of pneumonia. It includes 20 variables and depending on the score, patients are assigned into one of the 5 classes.<br />Class, I, II, III - at low risk of death and can be treated on an outpatient basis<br />Class IV &amp; V require hospitalization</p><hr><h3>Related Pearl: CURB-65 Criteria</h3><p>This is a score to determine the severity of pneumonia.</p>\n<p>The CURB-65 criteria include five variables(1 point for each variable):</p>\n<ul>\n<li><strong>C</strong>onfusion&nbsp;</li>\n<li>Blood <strong>U</strong>rea Nitrogen (BUN) &gt;7&nbsp;<span class=\"nowrap\">mmol/L</span></li>\n<li><strong>R</strong>espiratory rate &ge;30/min&nbsp;</li>\n<li><strong>B</strong>lood pressure, systolic &le;90 mmHg or diastolic &le;60 mmHg&nbsp;</li>\n<li>Age &ge;<strong>65</strong> years.</li>\n</ul>\n<p>Management:</p>\n<p><span class=\"medCalcFontOneBold\">0 point: Treat as an outpatient</span></p>\n<p><span class=\"medCalcFontOneBold\">1 to 2 points: Admitted to the hospital</span></p>\n<p><span class=\"medCalcFontOneBold\">&ge;3 points: ICU admission</span></p>\n<p><span class=\"medCalcFontOneBold\"><strong>Treatment of Community-Acquired Pneumonia</strong>&nbsp;</span></p>\n<p><span class=\"medCalcFontOneBold\">Score - 0: The drug of choice is macrolides. </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Azithromycin 500mg OD </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; or </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Clarithromycin&nbsp; 500mg BD </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; or </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Doxycycline&nbsp; 100mg BD.</span></p>\n<p><span class=\"medCalcFontOneBold\">Score - 1: Treated with azithromycin&nbsp; 500mg OD + ceftriaxone 2gm OD.</span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Respiratory quinolones (Levofloxacin) are not preferred. </span></p>\n<p><span class=\"medCalcFontOneBold\">Score - &gt;2: Azithromycin 500mg OD + Ceftriaxone 2gm IV OD and specific management.<br /></span></p>\n<p>NOTE:- In a<strong> modified </strong>version of the CURB-65, the criteria of blood urea nitrogen has been removed.</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;This elimination removes the need for lab testing.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1142",
      "difficulty": "easy"
    },
    {
      "text": "A 22-year-old female patient came with complaints of vomiting and a decrease in movement of the right leg. In the past, she has had episodes of violent and aggressive behavior and abdominal pain. Which of the following is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "AIDP with migraine"
        },
        {
          "id": 2,
          "text": "Right side paralysis"
        },
        {
          "id": 3,
          "text": "Acute intermittent porphyria"
        },
        {
          "id": 4,
          "text": "Conversion disorder"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario describing <strong>decrease</strong> in <strong>movement of right leg</strong> (neurological symptom) in a <strong>young female</strong> with history of <strong>episodic</strong> attacks of <strong>abdominal pain</strong> and <strong>aggressive behaviour</strong> (mental symptom) is consistent with the diagnosis of <strong>acute intermittent prophyria</strong>.</p>\n<p><strong>Conversion disorder</strong> (Option D) presents commonly in <strong>young women</strong> as <strong>acute</strong>, <strong>temporary loss</strong> of <strong>sensory or motor function</strong> preceded by <strong>psychological issues</strong>. Recurrent episodic attacks of neurovisceral symptoms make the diagnosis of conversion disorder unlikely.</p><p><strong>Acute intermittent porphyria</strong> (AIP) is a <strong>hepatic porphyria</strong> inherited in an <strong>autosomal dominant</strong> pattern. It occurs due to a <strong>deficiency</strong> of <strong>porphobilinogen</strong> <strong>deaminase</strong>/hydroxymethylbilane synthase/uroporphyrinogen I synthase enzyme in heme synthesis. AIP is generally latent before puberty and is <strong>more common</strong> in <strong>women</strong>.&nbsp;</p>\n<p>AIP presents with <strong>neurovisceral symptoms</strong> and <strong>no cutaneous manifestations</strong> are seen. <strong>Abdominal pain</strong> is the most common symptom. Nausea, vomiting, constipation, muscle weakness, sensory loss, dysuria, and urinary retention are seen. Tachycardia, hypertension, restlessness, tremors, and excess sweating are due to <strong>sympathetic overactivity</strong>. <strong>Peripheral neuropathy</strong> predominantly affecting motor neurons is due to <strong>axonal degeneration</strong>. During acute episodes, individuals may experience <strong>mental manifestations</strong> such as anxiety, insomnia, depression, hallucinations, and paranoia. <strong>Seizures</strong> may result from either neurological effects or <strong>hyponatremia</strong>.</p><p>Diagnosis can be made with the appearance of classic symptomology after exposure to an underlying precipitating factor. Plasma and urine <strong>ALA</strong> and <strong>PBG</strong> levels are <strong>significantly raised</strong> during an <strong>acute attack</strong> and <strong>remain high</strong> even after symptoms resolve.</p>\n<p><strong>Intravenous hematin</strong> as <strong>first-line treatment</strong> for <strong>acute attacks</strong>. Narcotic <strong>analgesia</strong> may be given for abdominal pain. <strong>Carbohydrate loading</strong> with <strong>intravenous glucose</strong> may be tried in <strong>milder attacks</strong>. <strong>Orthoptic liver transplant</strong> is curative in patients <strong>refractory to hemin therapy</strong>.</p>\n<p>Givosiran is a recently approved hepatic-targeted RNA interference (RNAi) therapy for acute hepatic porphyrias.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1145",
      "difficulty": "medium"
    },
    {
      "text": "A 36 year old male came with complaints of ascending weakness in both lower limbs and upper body. There was no history of trauma. Which of the following investigations is done in the evaluation of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Serum potassium"
        },
        {
          "id": 2,
          "text": "Serum magnesium"
        },
        {
          "id": 3,
          "text": "Serum sodium"
        },
        {
          "id": 4,
          "text": "Serum calcium"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given scenario describes a patient with <strong>ascending paralysis</strong>. Among the given options, <strong>Serum potassium</strong> (Option A) is <strong>tested</strong> as <strong>disturbances</strong> in <strong>serum potassium</strong> levels (hypokalemia or hyperkalemia) present with <strong>ascending muscle weakness</strong>.</p><p>Option B: <strong>Hypomagnesemia</strong> can cause <strong>tetany</strong>. <strong>Hypermagnesemia</strong> can cause <strong>generalized weakness</strong> and <strong>paralysis</strong>. However, serum potassium is a better answer as disturbances in potassium levels are more likely to cause paralysis.</p>\n<p>Option C: Alteration in <strong>serum sodium</strong> levels <strong>does not</strong> cause muscular <strong>paralysis</strong>.</p>\n<p>Option D : <strong>Hypocalcemia</strong> presents with <strong>paresthesia</strong>, <strong>tetany</strong>, <strong>seizures</strong> and <strong>prolonged QT interval</strong>. Hypercalcemia presents with other clinical features like fatigue, depression, mental confusion, anorexia, nausea, vomiting, constipation, reversible renal tubular defects, increased urine output, short QT interval in the electrocardiogram, and, in some patients, cardiac arrhythmias.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1163",
      "difficulty": "medium"
    },
    {
      "text": "On thyroid function test analysis, TSH value was much higher than normal with a low free T4. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Subclinical hypothyroidism"
        },
        {
          "id": 2,
          "text": "Hyperthyroidism"
        },
        {
          "id": 3,
          "text": "Secondary hypothyroidism"
        },
        {
          "id": 4,
          "text": "Primary hypothyroidism"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>An <strong>elevated TSH</strong> value with <strong>low free T4</strong> is suggestive of <strong>primary hypothyroidism</strong> (Option D).</p>\n<p>Option A: In <strong>subclinical hypothyroidism</strong>, free <strong>T4</strong> levels remain <strong>normal</strong> despite <strong>elevated TSH</strong>.</p>\n<p>Option B: <strong>TSH</strong> is <strong>low</strong> in <strong>hyperthyroidism</strong>.</p>\n<p>Option C: The diagnosis of <strong>secondary hypothyroidism</strong> is made along with a <strong>deficiency</strong> of <strong>other</strong> <strong>pituitary hormones</strong>. TSH levels may be low, normal, or slightly increased. The elevation in TSH levels can be attributed to the secretion of immunoreactive but biologically inactive forms of TSH. To <strong>confirm</strong> the <strong>diagnosis</strong>, it is essential to detect a <strong>low</strong> level of <strong>unbound T4</strong>.</p><p>The diagnostic approach to hypothyroidism is given in the flowchart below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/98ba447d91a2415cb2ccbe628103d66ax1280x2249.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Causes of Hypothyroidism</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Primary </strong></p>\n<p>(Low T3, T4 &rarr; Raised TSH levels)</p>\n</td>\n<td>\n<p><strong>Secondary</strong></p>\n<p><strong> </strong>(Low TSH levels &rarr; Low T3, T4)</p>\n</td>\n<td>\n<p><strong>Tertiary</strong></p>\n<p><strong> </strong>(Low TRH &rarr; Low TSH &rarr; Low T3,T4)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hashimoto&rsquo;s thyroiditis</strong></p>\n<p>RAI therapy for Grave&rsquo;s disease</p>\n<p>Post thyroidectomy</p>\n<p>Excessive iodine intake - Wolff Chiakoff effect</p>\n<p>Subacute thyroiditis</p>\n<p>Medications: Antithyroid drugs, lithium</p>\n<p>Iodine deficiency, dyshormonogenesis</p>\n</td>\n<td>\n<p><strong>Pituitary tumour</strong></p>\n<p>Pituitary resection or ablation</p>\n</td>\n<td>\n<p><strong>Hypothalamic insufficiency</strong></p>\n<p>Resistance to thyroid hormone</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1164",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is responsible for the elevated levels of TG and VLDL in diabetes mellitus?",
      "choices": [
        {
          "id": 1,
          "text": "Increased activity of lipoprotein lipase and decreased activity of hormone sensitive lipase"
        },
        {
          "id": 2,
          "text": "Increased activity of hormone sensitive lipase and decreased lipoprotein lipase activity"
        },
        {
          "id": 3,
          "text": "Increase in peripheral function of LDL receptors"
        },
        {
          "id": 4,
          "text": "Increased in activity of hepatic lipase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>The <strong>elevated</strong> levels of <strong>triglycerides</strong> (TG) and <strong>very low-density lipoproteins</strong> (VLDL) in <strong>diabetes mellitus</strong> (DM) are due to <strong>decreased activity</strong> of <strong>lipoprotein lipase</strong> (LpL) and <strong>increased activity</strong> of <strong>hormone-sensitive lipase</strong> (HSL).</p>\n<p><strong>Insulin</strong> <strong>normally</strong> has an <strong>inhibitory</strong> action on <strong>HSL</strong> and <strong>induces LpL</strong> on capillary walls. There is an absolute or relative deficiency of insulin in DM. In <strong>DM</strong>, the <strong>activity</strong> of <strong>LpL</strong> is <strong>decreased</strong> and <strong>HSL</strong> is <strong>increased</strong>.</p>\n<p>The increased activity of <strong>HSL</strong> results in <strong>increased mobilisation</strong> of <strong>fat stores</strong> towards <strong>lipolysis</strong> releasing fatty acids. These fatty acids are <strong>partly cleared</strong> <strong>by </strong>the<strong> liver</strong>, resulting in <strong>increased synthesis</strong> of <strong>VLDL</strong> and <strong>TG</strong>, resulting in <strong>dyslipidemia</strong>. They can <strong>accumulate</strong> in the liver, resulting in <strong>steatosis</strong> (non-alcoholic fatty liver disease).</p>\n<p>The reduced activity of LpL prevents the clearing of TG and VLDL in the bloodstream and their levels remain elevated.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/930c5ce53b9a48df908e15bf24113255x800x552.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Hormone sensitive lipase  Vs lipoprotein lipase</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;HSL</td>\n<td>&nbsp;Lipoprotein lipase</td>\n</tr>\n<tr>\n<td>Location</td>\n<td>&nbsp;Adipocyte</td>\n<td>&nbsp;Capillaries</td>\n</tr>\n<tr>\n<td>Action</td>\n<td>&nbsp;Hydrolyse TAG in adipose&nbsp; &nbsp;tissue</td>\n<td>&nbsp;Hydrolyse TAG in chylomicron , VLDL</td>\n</tr>\n<tr>\n<td>Acts in the state of</td>\n<td>&nbsp;Fasting (Glucagon)</td>\n<td>&nbsp;Fed (Insulin)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1486",
      "difficulty": "medium"
    },
    {
      "text": "What is the window period for thrombolysis in case of stroke?",
      "choices": [
        {
          "id": 1,
          "text": "1 ½  hours"
        },
        {
          "id": 2,
          "text": "2 ½ hours"
        },
        {
          "id": 3,
          "text": "3 ½ hours"
        },
        {
          "id": 4,
          "text": "4 ½ hours"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>window period</strong> for <strong>thrombolysis</strong> in case of stroke is <strong>4&frac12; hours</strong>.</p>\n<p><strong>Intravenous Recombinant Tissue Plasminogen Activator </strong>(IV&nbsp;rtPA) <strong>0.9 mg/kg</strong> upto a maximum of 90 mg, <strong>10% as bolus</strong>, the <strong>remainder</strong> as infusion <strong>over 60 min</strong> is given. <strong>Tenecteplase</strong> <strong>0.25 mg/kg</strong> IV bolus over 5 s is <strong>also used</strong>.</p>\n<p><strong>Blood pressure</strong> should be <strong>monitored</strong> frequently. <strong>No</strong> other <strong>antithrombotic therapy</strong> should be administered <strong>within</strong> a <strong>24-hour period</strong>. In the case of a <strong>deterioration</strong> in neurological condition or <strong>uncontrolled high blood pressure</strong>, the infusion should be stopped, <strong>cryoprecipitate</strong> should be administered, and <strong>urgent imaging</strong> of the <strong>brain</strong> should be done. It is recommended to refrain from urethral catheterization for a minimum of 2 hours.</p><hr><h3>Related Pearl: Indications and Contraindications of thrombolysis in Ischemic Stroke</h3><p><strong>Indications for thrombolysis in stroke</strong>&nbsp;</p>\n<ul>\n<li>Clinical diagnosis of stroke</li>\n<li>Onset of symptoms to time of drug administration &lt;3 hours/<strong>4.5</strong> hours</li>\n<li>Age &ge; 18 years</li>\n<li>CT scan showing no haemorrhage or edema of &gt;1/3<sup>rd</sup> of the MCA territory&nbsp;</li>\n</ul>\n<p><strong>Contraindications of thrombolysis in stroke&nbsp;</strong></p>\n<ul>\n<li>Sustained BP &gt;185/110 mmHg despite treatment</li>\n<li>Bleeding diathesis</li>\n<li>Recent head injury or Intracerebral hemorrhage</li>\n<li>Major surgery in preceding 14 days</li>\n<li>Minor stroke symptoms</li>\n<li>Gastrointestinal bleeding in preceding 21 days</li>\n<li>Recent myocardial infarction</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1507",
      "difficulty": "medium"
    },
    {
      "text": "A 53-year-old man was admitted with a history of a cerebrovascular accident. On the second day, he becomes drowsy with minimal response. CT finding is shown in the image below. What will be your next line of management?",
      "choices": [
        {
          "id": 1,
          "text": "Aspirin and clopidogrel"
        },
        {
          "id": 2,
          "text": "Mannitol"
        },
        {
          "id": 3,
          "text": "Decompressive surgery"
        },
        {
          "id": 4,
          "text": "Mechanical thrombectomy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario describes a 53 year old patient admitted in view of a <strong>cerebrovascular accident</strong> developing <strong>neurologic deterioration</strong> (drowsy with minimal response) on the <strong>second day</strong>, and <strong>CT brain</strong> showing significant <strong>edema of MCA territory</strong> with <strong>midline shift</strong>. The next line of management is <strong>decompressive surgery</strong>.</p>\n<p><strong>Cerebral edema</strong> is a potential <strong>complication in 5-10%</strong> of patients with <strong>strokes</strong>, leading to obtundation and brain herniation. The severity of edema is highest on the second or third day after the stroke and can last for around 10 days. </p>\n<p>Medical management may not be successful in case of significant edema or infarcts involving the cerebellum. </p>\n<p><strong>Decompressive surgery</strong> is recommended for patients who are <strong>less than 60 years</strong> old and experience <strong>deterioration ≤ 48 hours</strong>, despite receiving medical therapy. <strong>Hypodensity</strong> on <strong>head CT</strong> within the <strong>first 6 hours</strong> of stroke onset, involving <strong>≥ one-third of the MCA territory</strong>, early <strong>midline shift</strong>, and a diffusion-weighted imaging volume on MRI within 6 hours ≥ 80 mL are predictors of <strong>severe cerebral edema</strong>.</p><p>World Stroke Day is on October 29 every year. On this day, people everywhere share important information about recognizing the signs of a stroke, how to stay healthy, and ways to prevent strokes. The theme this year, as designated by WSO, is ‘Together we are #Greater Than Stroke.’ In India, the average stroke incidence rate is 145 per 1,00,000 population.</p><hr><h3>Related Pearl: Intracranial Hypertension</h3><p><strong>Definition</strong></p>\n<p>Intracranial hypertension is pressure within the cranium above normal. Normal range of ICP is 5-15mm Hg. Levels above 20-25mm Hg are usually treated.&nbsp;</p>\n<p><strong>Causes</strong>: Intracranial haemorrhage, brain tumors, head injury, meningitis, brain abscess, etc.&nbsp;</p>\n<p><strong>Symptoms of raised ICT</strong></p>\n<ul>\n<li><strong>Cushing&rsquo;s triad</strong> &ndash; hypertension, bradycardia and respiratory depression</li>\n<li>Headache, visual blurring due to papilloedema and abducent nerve palsy&nbsp;</li>\n<li>Focal symptoms may arise due to the local effects in patients with mass lesions or due to herniation.</li>\n<li>Seizures</li>\n<li>Stroke</li>\n</ul>\n<p><strong>Investigations</strong></p>\n<ul>\n<li>CT brain or MRI brain with gadolinium to rule out ICSOL&nbsp;</li>\n<li><strong>Lumbar puncture is contraindicated</strong> in the presence of raised ICT due to the risk of coning.</li>\n<li>Papilledema (as an indicator of ICT) should be ruled out before lumbar puncture.</li>\n</ul>\n<p><strong>Treatment</strong></p>\n<ul>\n<li>Dexamethasone</li>\n<li>Ventriculotomy to remove CSF or ventriculoperitoneal shunt</li>\n<li>Decompressive craniectomy</li>\n<li>Surgical resection of ICSOL &ndash; by craniotomy or stereotactic radiosurgery</li>\n<li>Whole brain radiation for multiple metastases causing raised ICT</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5a0119c357cf4c85a06e09ed00c0843e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9286",
      "difficulty": "medium"
    },
    {
      "text": "Disappearance of loud S1 in mitral stenosis occurs in all except:",
      "choices": [
        {
          "id": 1,
          "text": "First degree heart block"
        },
        {
          "id": 2,
          "text": "AR"
        },
        {
          "id": 3,
          "text": "Calcified valve"
        },
        {
          "id": 4,
          "text": "Mild MS"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Loud S1</strong> is heard in <strong>mild mitral stenosis</strong> (MS).</p>\n<p>The <strong>intensity of S1</strong> depends on the <strong>distance</strong> over which the <strong>anterior leaflet </strong>of the mitral valve <strong>moves</strong>, <strong>leaflet mobility</strong>, <strong>LV contractility</strong>, and <strong>PR interval</strong>. It is independent of the severity of MS.</p>\n<p>Loud S1 is seen in early rheumatic MS, short PR interval, and hyperdynamic circulatory states.</p>\n<p>S1 becomes soft in case of calcified leaflets, long PR interval, associated aortic regurgitation and LV dysfunction.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9209",
      "difficulty": "medium"
    },
    {
      "text": "The given ECG depicts which of the following conditions:",
      "choices": [
        {
          "id": 1,
          "text": "Paroxysmal supraventricular tachycardia"
        },
        {
          "id": 2,
          "text": "Ventricular bigeminy"
        },
        {
          "id": 3,
          "text": "P pulmonale"
        },
        {
          "id": 4,
          "text": "Re-entrant atrial fibrillation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given ECG shows a <strong>premature ventricular complex</strong> (PVC) that <strong>occurs every second beat</strong> (ventricular bigeminy).</p>\n<p><strong>PVCs</strong> exhibit <strong>premature timing</strong> by arising <strong>before</strong> the <strong>anticipated occurrence</strong> of the <strong>subsequent regular heartbeat</strong>. They display an aberrant QRS-T appearance, where the <strong>QRS complex</strong> appears unusually <strong>wide</strong> (0.12 sec or longer), and the <strong>T wave</strong> and <strong>QRS complex</strong> point in <strong>opposite&nbsp;orientations</strong> (discordant).</p>\n<p>Frequent PVCs can manifest in different patterns. When two PVCs occur consecutively, they are termed a pair or couplet.</p>\n<p>If <strong>three or more PVCs</strong> occur in <strong>succession</strong> (triplet), it is classified as <strong>ventricular tachycardia</strong> (VT). The <strong>repetitive pattern</strong> of <strong>one normal beat followed by one PVC</strong> is known as <strong>ventricular bigeminy</strong>.</p>\n<p>When the repeating sequence involves two normal beats followed by a PVC, it is called ventricular trigeminy. Similarly, if three normal beats are followed by a PVC, it is referred to as ventricular quadrigeminy.</p><p>The ECG below shows ventricular bigeminy where every normal QRS (green underlines) is followed by a PVC (red arrows):</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/167918b3d1664820afab57a443544f15x720x424.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Normal ECG waves and intervals</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>ECG wave/interval</strong></p>\n</td>\n<td>\n<p><strong>Physiological correlates</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>P wave</p>\n</td>\n<td>\n<p>Atrial depolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>QRS complex (up to 0.10s)</p>\n</td>\n<td>\n<p>Ventricular depolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T wave</p>\n</td>\n<td>\n<p>Ventricular repolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>U wave</p>\n</td>\n<td>\n<p>Repolarization of ventricular myocytes with long action potential</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PR interval&nbsp; (0.12-0.2s)&nbsp;</p>\n</td>\n<td>\n<p>Atrial depolarization and conduction through AV node</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>QT interval&nbsp; (up to 0.43s)</p>\n</td>\n<td>\n<p>Ventricular depolarization and Ventricular repolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ST interval (Average 0.32s)</p>\n<p>(QT minus QRS)</p>\n</td>\n<td>\n<p>Plateau portion of ventricular action potential+ Ventricular repolarisation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ST segment</p>\n</td>\n<td>\n<p>Plateau portion of ventricular action potential</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/70e10acc7b9f4c249713071ae9311e21x1280x1789.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/29d37704d3704abaa0afb38541882ed7.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9231",
      "difficulty": "easy"
    },
    {
      "text": "As an intern in the emergency ward, which of the following method would you consider as correct regarding nasogastric tube length estimation?",
      "choices": [
        {
          "id": 1,
          "text": "Tip of nose to ear to xiphisternum"
        },
        {
          "id": 2,
          "text": "Tip of nose to angle of ear to umbilicus"
        },
        {
          "id": 3,
          "text": "Mouth to ear to umbilicus"
        },
        {
          "id": 4,
          "text": "Mouth to ear to midway between xiphisternum and umbilicus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The commonly used method to determine the <strong>length</strong> of a <strong>nasogastric tube</strong> is the <strong>NEX method</strong>: the <strong>tip of the nose </strong>to&nbsp;the<strong> ear </strong>to the<strong> xiphisternum</strong>.</p>\n<p>The <strong>approximate length</strong> is <strong>120-125 cm</strong>. The markings indicate the traversing of the tube through various parts of the GIT:</p>\n<ul>\n<li aria-level=\"1\">40 cm: Cardia of the stomach</li>\n<li aria-level=\"1\">50 cm: Body of the stomach</li>\n<li aria-level=\"1\">60 cm: Pylorus</li>\n<li aria-level=\"1\">70 cm: Duodenum</li>\n</ul>\n<p>A nasogastric tube or Ryle's tube is inserted in the<strong> sitting position</strong> with the <strong>neck slightly flexed</strong>. The tube is then gently inserted through the nostril and advanced until it reaches 10 cm. The patient is encouraged to swallow, allowing the tube to move down the esophagus with successive swallows until it reaches the measured distance.</p>\n<p>Subjective confirmation involves insufflating air through the proximal opening of the NG tube and listening for the sound of air in the left upper quadrant where the stomach is located. <strong>Objective confirmation</strong> can be obtained through <strong>pH measurement</strong>, <strong>chest or abdominal radiographs</strong>, ultrasound, or calorimetric capnometry.</p>\n<p>While widely practiced, blind NG tube insertion can lead to complications such as coiling of the tube in the nasopharynx, incorrect placement in the bronchial passage, or even esophageal perforation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9233",
      "difficulty": "easy"
    },
    {
      "text": "A morbidly obese diabetic woman is not responsive to metformin therapy. She has a history of pancreatitis and family history of bladder cancer. She does not want to take injections. Which of the following would be suitable to reduce her glucose levels?",
      "choices": [
        {
          "id": 1,
          "text": "Sitagliptin"
        },
        {
          "id": 2,
          "text": "Pioglitazone"
        },
        {
          "id": 3,
          "text": "Canagliflozin"
        },
        {
          "id": 4,
          "text": "Liraglutide"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Among the given options, <strong>canagliflozin</strong> (Option C) is the most <strong>suitable treatment</strong>. It is an <strong>oral drug</strong> belonging to the class <strong>SGLT-2 inhibitors</strong> and causes <strong>weight loss</strong>. Although it increases the risk of urogenital infections, it has <strong>no risk</strong> of <strong>pancreatitis</strong> or <strong>bladder cancer</strong>.</p>\n<p>Option A: <strong>Sitagliptin</strong>, a DPP-IV inhibitor, is associated with the risk of <strong>acute pancreatitis</strong>.</p>\n<p>Option B: <strong>Pioglitazone</strong>, a thiazolidinedione, can increase the risk of <strong>bladder cancer</strong> and can cause weight gain and <strong>congestive cardiac failure</strong>.</p>\n<p>Option D: <strong>Liraglutide</strong> is an injectable GLP-1 receptor agonist. <strong>Pancreatitis</strong> is a serious adverse effect of this drug. Hence, it is contraindicated in individuals with a history of pancreatitis and should be permanently discontinued if pancreatitis develops.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9260",
      "difficulty": "medium"
    },
    {
      "text": "A patient has a right upper limb BP of 180/95 mm Hg and a left upper limb BP of 130/90 mm Hg. He also has an early diastolic murmur in right 2nd intercostal space. Which of the following is least likely to be associated with these findings?",
      "choices": [
        {
          "id": 1,
          "text": "Supravalvular aortic stenosis"
        },
        {
          "id": 2,
          "text": "Coarctation of aorta"
        },
        {
          "id": 3,
          "text": "Takayasu arteritis"
        },
        {
          "id": 4,
          "text": "Aortic dissection"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A <strong>significant difference</strong> in <strong>blood pressure</strong> measured <strong>between two arms</strong> (&gt;10 mm Hg) may be seen in Takayasu arteritis (subclavian artery disease), <strong>supravalvular aortic stenosis</strong>, aortic coarctation, and aortic dissection (all four options).</p>\n<p>An <strong>early diastolic murmur</strong> in the <strong>right second intercostal space</strong> (aortic area) is suggestive of <strong>aortic regurgitation</strong>. <strong>Supravalvular aortic stenosis</strong> (Option A), which involves the part of the aorta distal to the aortic valve, is <strong>unlikely</strong> to cause <strong>aortic regurgitation</strong> and hence the best answer.</p>\n<table>\n<tbody>\n<tr>\n<td>Features&nbsp;</td>\n<td>Supravalvular AS</td>\n<td>Takayasu arteritis</td>\n<td>Aortic dissection</td>\n<td>Coarctation of aorta</td>\n</tr>\n<tr>\n<td>Aortic regurgitation</td>\n<td>Unlikely</td>\n<td>Present in 25% of cases</td>\n<td>Present in acute situations</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>BP difference between arms</td>\n<td>Present</td>\n<td>Present</td>\n<td>Present</td>\n<td>May be present</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p>So the single best answer would be <strong>Supravalvular AS &gt; Coarctation of the aorta.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9299",
      "difficulty": "medium"
    },
    {
      "text": "A young donor came to the blood bank for the first time for platelet apheresis with platelet count of 1.9L. During the course he developed paresthesias and circumoral numbness during donation. His vitals remained stable though. ECG showed tachycardia with ST-T changes. What is the reason for his symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Hypovolemic shock"
        },
        {
          "id": 2,
          "text": "Hypocalcemia"
        },
        {
          "id": 3,
          "text": "Seizures"
        },
        {
          "id": 4,
          "text": "Allergic reaction"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario of a young patient developing <strong>paresthesia</strong> and <strong>circumoral numbness</strong> and ECG showing <strong>ST-T changes</strong> during blood donation for <strong>platelet apheresis</strong> is consistent with <strong>hypocalcemia</strong>.&nbsp;</p>\n<p>Hypocalcemia in this case is due to <strong>citrate</strong> which is used as an <strong>anticoagulant</strong> in apheresis machine. Citrate is a calcium chelator and bind to the calcium in the donor&rsquo;s circulation.&nbsp;</p>\n<p>During a physical examination, <strong>Chvostek's sign</strong> (twitching of the muscles around the mouth when the facial nerve is gently tapped) and <strong>Trousseau's sign</strong> (carpal spasm induced by inflating a blood pressure cuff to 20 mmHg above the patient's systolic blood pressure for 3 minutes) may be seen. Severe hypocalcemia can lead to various complications including seizures, spasms in the hands and feet (carpopedal spasm), bronchospasm, laryngospasm, and QT prolongation.</p>\n<p>For acute and symptomatic hypocalcemia, the <strong>initial treatment</strong> involves <strong>intravenous</strong> administration of <strong>calcium gluconate</strong>, usually <strong>10 mL of a 10% solution</strong> given over <strong>5 minutes</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9120",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following anti-diabetic drugs should be stopped in a patient with a creatinine of 5.6 mg/dL?",
      "choices": [
        {
          "id": 1,
          "text": "Metformin"
        },
        {
          "id": 2,
          "text": "Linagliptin"
        },
        {
          "id": 3,
          "text": "Metoprolol"
        },
        {
          "id": 4,
          "text": "Insulin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Metformin</strong> should be <strong>stopped</strong> in case of <strong>elevated creatinine levels</strong> (renal insufficiency) <strong>&gt; 1.5 mg/dl in men</strong> and <strong>&gt;1.4 mg/dl in women</strong>.</p>\n<p>Metformin acts by <strong>reducing hepatic glucose production</strong> and <strong>improves peripheral glucose utilization</strong>. Lactic acidosis and Vitamin B12 deficiency are specific adverse effects of metformin. It is <strong>not</strong> used in patients with a&nbsp;<strong>glomerular filtration rate &lt;30 mL/min&nbsp;</strong>(moderate renal insufficiency), acidosis, unstable congestive cardiac failure, liver disease, severe hypoxemia, and patients undergoing contrast studies.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9265",
      "difficulty": "easy"
    },
    {
      "text": "A 53-year-old patient was admitted complains of dyspnea. On examination he has puffy face with engorged veins over the chest. SVC obstruction is suspected. Chest X-ray shows mediastinal enlargement. What is the next step?",
      "choices": [
        {
          "id": 1,
          "text": "Total blood count with peripheral smear"
        },
        {
          "id": 2,
          "text": "CT thorax"
        },
        {
          "id": 3,
          "text": "Start cyclophosphamide"
        },
        {
          "id": 4,
          "text": "Urgent referral to RT"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In a patient with <strong>suspected superior vena cava syndrome</strong> (SVCS), the <strong>next step</strong> is to perform a <strong>CT thorax</strong> to confirm the diagnosis and determine the underlying cause. CT reveals <strong>reduced</strong> or <strong>absent opacification</strong> of <strong>central venous structures</strong> along with noticeable <strong>collateral venous circulation</strong>.</p>\n<p>The diagnosis of SVCS is primarily clinical, but imaging can aid the diagnosis. The <strong>chest radiographic</strong> finding commonly observed in SVCS is the <strong>widening of the superior mediastinum</strong>. <strong>MRI</strong> can be used to diagnose <strong>SVC obstruction</strong> with <strong>100% sensitivity and specificity</strong>. Invasive procedures like bronchoscopy or biopsy may be performed if needed.</p><p>SVCS is caused by the obstruction of the superior vena cava, resulting in impaired blood flow from the head, neck, and upper extremities. <strong>Lung cancer</strong> is the <strong>most common cause</strong> of <strong>malignant SVCS</strong> cases. In <strong>young adults</strong>, <strong>malignant lymphoma</strong> followed by <strong>mediastinal germ cell tumors</strong> are the leading causes of SVCS. The use of intravascular devices such as central venous catheters has led to an increase in benign causes of SVCS.</p>\n<p>Patients with SVCS present with swelling of the neck and face, dyspnea, cough, hoarseness, headaches, nasal congestion, and pain. <strong>Bending forward</strong> or <strong>lying down</strong> may <strong>aggravate </strong>the<strong> symptoms</strong>. Physical examination may reveal <strong>dilated neck veins</strong>, <strong>collateral veins</strong> on the <strong>chest wall</strong>, <strong>cyanosis</strong>, and <strong>edema</strong> of the face, arms, and chest.</p>\n<p><strong>Cerebral and laryngeal edema</strong> are rare but serious <strong>complications</strong> associated with SVCS, and they require urgent evaluation.&nbsp;</p><p>Treatment of SVCS depends on the underlying cause. <strong>Radiation therapy</strong> is the <strong>primary treatment</strong> for SVCS caused by <strong>non-small-cell lung cancer</strong> and metastatic solid tumors. <strong>Chemotherapy</strong> is effective for <strong>small-cell lung cancer</strong>, lymphoma, and germ cell tumors. Intravascular stenting is often used to provide rapid relief of symptoms.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9149",
      "difficulty": "easy"
    },
    {
      "text": "A patient with ascites is found to have SAAG ≥1.1 . All the following can be the causes except",
      "choices": [
        {
          "id": 1,
          "text": "Cirrhosis"
        },
        {
          "id": 2,
          "text": "Liver failure"
        },
        {
          "id": 3,
          "text": "Metastasis to liver"
        },
        {
          "id": 4,
          "text": "TB peritonitis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>serum ascites albumin gradient</strong> (SAAG) in ascites due to <strong>TB peritonitis</strong>&nbsp;is <strong>&lt; 1.1 g/dL</strong> as it is unrelated to portal hypertension.&nbsp;</p>\n<p><strong>SAAG</strong> helps <strong>differentiate ascites</strong> caused by <strong>portal hypertension from nonportal hypertensive ascites</strong>. A SAAG <strong>&ge;1.1 g/dL</strong> indicates <strong>portal hypertension</strong> and suggests causes such as cirrhosis, cardiac ascites, hepatic vein thrombosis, sinusoidal obstruction syndrome, or liver metastases. A SAAG <strong>&lt;1.1 g/dL</strong> suggests other causes like <strong>tuberculous peritonitis</strong>, peritoneal carcinomatosis, or pancreatic ascites. For high-SAAG ascites, the ascitic protein level provides additional information. A protein level of <strong>&ge;2.5 g/dL</strong> suggests <strong>normal hepatic sinusoids</strong>, while <strong>&lt;2.5 g/dL</strong> indicates <strong>damaged</strong> and <strong>scarred sinusoids</strong>. Pro-brain-type natriuretic peptide (BNP) levels may help identify heart failure as the cause of high-SAAG ascites.</p>\n<p>Additional tests may be conducted in specific clinical situations, such as measuring ascitic glucose and lactate dehydrogenase (LDH) levels for suspected secondary peritonitis, ascitic amylase levels for suspected pancreatic ascites, and cytology for peritoneal carcinomatosis.&nbsp;</p>\n<p><strong>Tuberculous peritonitis</strong> may be associated with <strong>ascitic fluid lymphocytosis</strong>. The sensitivity of the smear for acid-fast bacilli and culture is low. <strong>Elevated ascitic adenosine deaminase</strong> &gt; 30&ndash;45 U/L is <strong>highly sensitive</strong>.</p><hr><h3>Related Pearl: Serum Ascites Albumin Gradient  (SAAG)</h3><p>The serum ascites albumin gradient is calculated as follows:</p>\n<p>SAAG = Serum albumin - Ascitic fluid albumin</p>\n<p>It can be used to determine the cause of ascites following ascitic fluid analysis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/08ad7499e5e74b398f3c98a430c6af02x1200x1361.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9157",
      "difficulty": "medium"
    },
    {
      "text": "A patient on anti-tubercular therapy develops tingling sensation in the limbs. Which of the following when substituted can result in improvement of symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Thiamine"
        },
        {
          "id": 2,
          "text": "Pyridoxine"
        },
        {
          "id": 3,
          "text": "Folic acid"
        },
        {
          "id": 4,
          "text": "Methylcobalamine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In a patient on <strong>anti-tubercular therapy</strong> (ATT), the development of a <strong>tingling</strong> sensation is suggestive of <strong>isoniazid</strong> (INH) <strong>related peripheral neuropathy</strong>. In adults, <strong>pyridoxine</strong> (100 mg/day) is given until symptoms subside.</p>\n<p>Alcoholics, malnourished persons, pregnant and lactating women, and patients with chronic renal failure, diabetes, and HIV infection are at higher risk of peripheral neuropathy. Patients <strong>not responding</strong> to <strong>pyridoxine</strong> may be treated with <strong>amitriptyline</strong>. Mothers receiving INH (10mg/day), their infants (5 mg/day), and all children receiving INH (10mg/day) should receive pyridoxine supplementation. Adults (50 mg/day) and children &gt; 1 year (25 mg/day) on isoniazid preventive therapy are also supplemented with pyridoxine.</p>\n<p><strong>Drug-induced liver injury</strong> is another adverse effect of <strong>INH</strong>. Liver enzymes more than three times the upper limit with symptomatic jaundice or liver enzymes more than five times the upper limit in asymptomatic patients may warrant cessation of INH.</p>\n<p><strong>Ethionamide</strong>, a second-line anti-tubercular drug, also causes <strong>neurological adverse effects</strong> and may require pyridoxine supplementation.</p><hr><h3>Related Pearl: Key points on the first line drugs used in the treatment of TB</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Drugs</strong></span></td>\n<td><span><strong>Isoniazid</strong></span></td>\n<td><span><strong>Rifamycins</strong></span></td>\n<td><span><strong>Pyrazinamide</strong></span></td>\n<td><span><strong>Ethambutol</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Mechanism of action</strong></span></td>\n<td>\n<p><span>Bactericidal</span></p>\n<p><span>Blocks mycolic acid synthesis.</span></p>\n</td>\n<td>\n<p><span>Bactericidal (maximum)</span></p>\n<p><span>Inhibition of RNA polymerase, leading to the inhibition of RNA synthesis.</span></p>\n</td>\n<td>\n<p><span>Bactericidal</span></p>\n<p><span>Inhibition of fatty acid synthase-I, leading to the inhibition of the cell membrane.</span></p>\n</td>\n<td>\n<p><span><strong>Bacteriostatic</strong></span></p>\n<p><span>Inhibition of arabinosyl transferase, leading to a reduction in arabinogalactan needed for the cell wall.</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Location of Mycobacteria</strong></span></td>\n<td><span>Intracellular +&nbsp; Extracellular</span></td>\n<td><span>Intracellular +&nbsp; Extracellular</span></td>\n<td><span>&nbsp;Intracellular</span></td>\n<td>&nbsp;<span>Extracellular</span></td>\n</tr>\n<tr>\n<td><span><strong>Metabolism</strong></span></td>\n<td><span>Liver&nbsp;</span></td>\n<td><span>Liver (maximum)</span></td>\n<td><span>&nbsp;Liver</span></td>\n<td>&nbsp;<span>Kidney</span></td>\n</tr>\n<tr>\n<td><span><strong>Unique side effects</strong></span></td>\n<td>\n<p><span>Shoulder hand syndrome and CNS side effects.</span></p>\n</td>\n<td><span>Orange urine, sweat, and tears. Flu-like symptoms with intermittent dosing.</span></td>\n<td>\n<p><span>The most hepatotoxic drug. It also causes hyperuricemia.</span></p>\n</td>\n<td>\n<p><span>Optic neuritis and hence, not preferred in children.</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Mechanism of resistance</strong></span></td>\n<td>\n<p><span>Kat G mutation- the most severe form of resistance.</span></p>\n<p><span>Inh a gene overexpression-&nbsp; confers cross-resistance with ethionamide.</span></p>\n</td>\n<td>\n<p class=\"p1\"><span>Mutation in <em>rpoB-</em>&nbsp;the gene coding for the <span class=\"s1\">&beta; </span>subunit of RNA polymerase.</span></p>\n</td>\n<td><span>Mutation of the&nbsp;<em>Pnca</em> gene.</span></td>\n<td>\n<p class=\"p1\"><span>Mutations in the <em>embB</em> gene.</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9185",
      "difficulty": "easy"
    },
    {
      "text": "A patient comes to ED with fever and headache. On examination he has neck stiffness. CSF analysis was done and it shows the following findings. Most likely diagnosis is:<div class='question-desc-html'><p>Opening pressure – Increased</p>\n<p>Proteins- Mildly increased</p>\n<p>Glucose – Normal</p>\n<p>Lymphocytes – Increased.</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "TB"
        },
        {
          "id": 2,
          "text": "Neisseria Gonorrhoea"
        },
        {
          "id": 3,
          "text": "Cryptococcus"
        },
        {
          "id": 4,
          "text": "Coxsackie"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given symptoms cluster of <strong>fever</strong>, <strong>vomiting,</strong> and <strong>neck stiffness</strong> is suggestive of <strong>meningitis</strong>. A CSF analysis showing <strong>increased opening pressure</strong>, <strong>lymphocytic pleocytosi</strong>s, mildly <strong>increased protein</strong>, and <strong>normal glucose</strong> is suggestive of <strong>viral meningitis</strong>. Among the given options, <strong>Coxsackie</strong> (Option D) is the only viral cause of meningitis. </p><p>Other options:</p>\n<p>Option A: <strong>Tuberculous</strong> meningitis shows <strong>lymphocytic pleocytosis</strong> with <strong>low glucose</strong>.</p>\n<p>Option B: <strong>Bacterial</strong> meningitis shows <strong>neutrophilic pleocytosis</strong> with <strong>low glucose</strong>.</p>\n<p>Option C: <strong>Fungal</strong> meningitis shows <strong>lymphocytic/neutrophilic pleocytosis</strong> with <strong>low glucose</strong>.</p><hr><h3>Related Pearl: CSF findings in meningitis</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Glucose&nbsp;</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>Protein</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>WBC (per&nbsp;&mu;L)</strong></td>\n</tr>\n<tr>\n<td><strong>Normal</strong></td>\n<td>40-85</td>\n<td>15-45</td>\n<td>\n<p>&lt;5</p>\n<p>60-70% lymphocytes, &le;30% monocytes / macrophages</p>\n</td>\n</tr>\n<tr>\n<td><strong>Bacterial</strong></td>\n<td>&lt;40</td>\n<td>&gt;100</td>\n<td>\n<p>&gt;1000</p>\n<p>&uarr;&uarr;PMNs (&ge;80%)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Viral</strong></td>\n<td>Normal</td>\n<td>20-80</td>\n<td>\n<p>25-500</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Tuberculous</strong></td>\n<td>&lt;50 <br />in 75% cases</td>\n<td>100-200</td>\n<td>\n<p>25-100</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Fungal</strong></td>\n<td>&darr; to normal</td>\n<td>150-300</td>\n<td>\n<p>40-600</p>\n<p>Lymphocytes or PMNs, depending on specific organism</p>\n</td>\n</tr>\n<tr>\n<td><strong>Parasitic</strong></td>\n<td>Normal</td>\n<td>50-200&nbsp;</td>\n<td>\n<p>150-2000</p>\n<p>&uarr;&uarr; Eosinophils (&ge;50%)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9159",
      "difficulty": "medium"
    },
    {
      "text": "Metabolic acidosis with a normal anion gap is seen in all except _____.",
      "choices": [
        {
          "id": 1,
          "text": "Proximal RTA"
        },
        {
          "id": 2,
          "text": "Pancreatitis"
        },
        {
          "id": 3,
          "text": "Severe diarrhoea"
        },
        {
          "id": 4,
          "text": "Salicylate poisoning"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the given options, <strong>salicylate poisoning</strong> (Option D) causes <strong>high anion gap metabolic acidosis</strong>. Proximal renal tubular acidosis, pancreatitis, and severe diarrhea are causes of normal anion gap acidosis.</p>\n<p><strong>Metabolic acidosis</strong> can be caused by <strong>increased production</strong> of <strong>endogenous acids</strong>, <strong>loss of bicarbonate</strong>, or <strong>impaired acid excretion</strong> by the kidneys. <strong>Blood pH decreases</strong>, leading to increased ventilation, particularly in tidal volume (Kussmaul respiration). It can be categorized into two main types: high-anion gap and non-anion gap acidosis.</p><hr><h3>Related Pearl: Causes of Metabolic Acidosis</h3><table>\n<tbody>\n<tr>\n<td>High Anion-Gap Metabolic Acidosis (MUDPILES)</td>\n<td>Normal Anion-Gap Metabolic Acidosis (FUSED CAR)</td>\n</tr>\n<tr>\n<td><strong>M</strong>ethanol</td>\n<td><strong>F</strong>istula pancreatic</td>\n</tr>\n<tr>\n<td><strong>U</strong>remia (Renal failure - Acute or Chronic)</td>\n<td><strong>U</strong>reterosigmoidostomy</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetic ketoacidosis</td>\n<td><strong>S</strong>mall bowel fistula</td>\n</tr>\n<tr>\n<td><strong>P</strong>araldehyde</td>\n<td><strong>E</strong>xtra chloride (Hyperalimentation)</td>\n</tr>\n<tr>\n<td><strong>I</strong>ron tablets, INH</td>\n<td><strong>D</strong>iarrhea</td>\n</tr>\n<tr>\n<td><strong>L</strong>actic acidosis</td>\n<td><strong>C</strong>arbonic anhydrase inhibitor (acetazolamide)</td>\n</tr>\n<tr>\n<td><strong>E</strong>thylene glycol</td>\n<td><strong>A</strong>ddison's disease</td>\n</tr>\n<tr>\n<td><strong>S</strong>alicylates</td>\n<td><strong>R</strong>enal tubular acidosis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9202",
      "difficulty": "medium"
    },
    {
      "text": "What is the drug of choice for scrub typhus?",
      "choices": [
        {
          "id": 1,
          "text": "Doxycycline"
        },
        {
          "id": 2,
          "text": "Ciprofloxacin"
        },
        {
          "id": 3,
          "text": "Chloramphenicol"
        },
        {
          "id": 4,
          "text": "Azithromycin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>drug </strong>of <strong>choice</strong> for <strong>scrub typhus</strong> is <strong>doxycycline. </strong></p>\n<p>To treat scrub typhus, oral doxycycline <strong>100</strong> <strong>mg </strong>is given<strong> twice daily</strong> for <strong>7–15 days</strong>. In the case of <strong>pregnant women</strong>, oral <strong>azithromycin </strong>500 mg for 3 days may be used as doxycycline is contraindicated in pregnancy.</p>\n<p>Scrub typhus is a <strong>rickettsial infection</strong> caused by <strong><em>Orientia tsutsugamushi</em></strong>. The vector is a <strong>trombiculid mite</strong>. Humans are infected when they are bitten by the mite larvae known as <strong>chiggers</strong>. The incubation period is 1- 3 weeks. Patients develop a characteristic<strong> eschar</strong> at the site of the mite bite, along with<strong> regional lymphadenopathy</strong> and <strong>maculopapular rash</strong>. It can be associated with fever, headache, myalgia, meningoencephalitis, myocarditis, and pneumonia.</p>\n<p><strong>Serologic assays</strong> are used for diagnosis. <strong>Weil-Felix reaction</strong> is a heterophile agglutination reaction used for diagnosis, wherein the sera are tested for agglutinins to the O antigens of Proteus strains OX19, OX2, and OXK. <strong>OXK</strong> alone is <strong>agglutinated</strong> in scrub typhus.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9169",
      "difficulty": "easy"
    },
    {
      "text": "A patient came with sudden onset palpitations. ECG showed a narrow complex, regular tachycardia without P waves, and a rate of 160 BPM. His blood pressure is 96/68 mmHg. What is the next step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Carotid sinus massage"
        },
        {
          "id": 2,
          "text": "Adenosine"
        },
        {
          "id": 3,
          "text": "Beta-blocker"
        },
        {
          "id": 4,
          "text": "Defibrillator"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario and the electrocardiogram (ECG) showing <strong>narrow QRS complex regular tachycardia without P waves</strong> are suggestive of paroxysmal supraventricular tachycardia (<strong>PSVT</strong>). The next step in the management of PSVT in a <strong>hemodynamically stable</strong> (systolic blood pressure &gt;90 mm Hg) patient is vagotonic maneuvres such as <strong>carotid sinus massage</strong> or Valsalva maneuver.</p>\n<p>Carotid sinus massage can be considered in the absence of carotid bruits and no history of stroke. If vagal maneuvers fail or cannot be performed, <strong>intravenous adenosine</strong> can be used. </p>\n<p>Non-DHP <strong>calcium channel blockers</strong> and <strong>beta blockers</strong> are second-line pharmacological agents in the management of PSVT. They can cause <strong>hypotension</strong> before and after terminating the arrhythmia.</p>\n<p>If the patient is <strong>hemodynamically unstable</strong> (systolic blood pressure &lt;90 mmHg or mean arterial pressure &lt;65 mm Hg), immediate <strong>QRS-synchronous direct current cardioversion</strong> is necessary.</p>\n<p>The treatment algorithm for PSVT is described in the flowchart below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d8076b463c924c27b49b4479ac3c46b2x1279x1416.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Supraventricular tachycardias</h3><p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with narrow QRS complex:</strong></p>\n<ul>\n<li><strong>Narrow QRS with regular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Sinus tachycardia</strong></td>\n<td>Normal P wave, normal ECG features except for the rate</td>\n</tr>\n<tr>\n<td><strong>Focal atrial tachycardia</strong></td>\n<td>A single type of abnormal p wave morphology is seen</td>\n</tr>\n<tr>\n<td><strong>Junctional tachycardia</strong></td>\n<td>No p waves. Heart rate is 100- 200/ min</td>\n</tr>\n<tr>\n<td><strong>AV nodal reentry tachycardia</strong></td>\n<td>No p waves. Pseudo R' waves may be seen. Heart rate is 150-250/ min</td>\n</tr>\n<tr>\n<td><strong>Atrioventricular reentry tachycardia</strong></td>\n<td>P wave always follows QRS. RP interval&lt; PR interval</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter</strong></td>\n<td>Sawtooth shaped flutter waves are seen</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Narrow QRS with irregular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;<strong>Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Atrial fibrillation</strong></td>\n<td>No distinct p waves seen</td>\n</tr>\n<tr>\n<td><strong>Multifocal atrial tachycardia</strong></td>\n<td>More than 3 different abnormal p wave morphologies are seen</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter/tachycardia with variable block</strong></td>\n<td>ECG features of heart block are seen.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with wide QRS complex:</strong></p>\n<ul>\n<li>Antidromic AVRT (atrioventricular reentry tachycardia)</li>\n<li>Supraventricular tachycardias with bundle branch block</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9280",
      "difficulty": "medium"
    },
    {
      "text": "Management of hyperkalaemia includes all except",
      "choices": [
        {
          "id": 1,
          "text": "Calcium gluconate"
        },
        {
          "id": 2,
          "text": "Insulin drip"
        },
        {
          "id": 3,
          "text": "Salbutamol nebulisation"
        },
        {
          "id": 4,
          "text": "Magnesium sulphate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the given options, <strong>magnesium sulphate</strong> has <strong>no role</strong> in the management of <strong>hyperkalemia</strong>.</p>\n<p>Hyperkalemia is a <strong>medical emergency</strong> that requires urgent treatment. Even in the <strong>absence of ECG changes</strong>, patients with <strong>plasma K+ concentration &ge;6.5 mEq/L&nbsp;</strong>should be aggressively managed.</p>\n<p><strong>Intravenous calcium gluconate</strong> (10 mL of 10% solution) is administered over 2-3 minutes with cardiac monitoring to protect the heart while other measures are taken to correct hyperkalemia. Calcium <strong>increases</strong> the <strong>threshold of action potential</strong> thereby <strong>reducing excitability</strong>.&nbsp;</p>\n<p><strong>Insulin-dextrose infusion</strong> is given to <strong>shift potassium into cells</strong>. The recommended dose is 10 units of regular insulin followed immediately by 50 mL of 50% dextrose. &beta;2-agonists like <strong>salbutamol</strong> can also be used in conjunction with insulin.</p>\n<p><strong>Cation exchange resins</strong>, <strong>diuretics</strong>, and <strong>dialysis</strong> are used to <strong>eliminate potassium</strong>. Sodium polystyrene sulfonate is a cation exchange resin that exchanges sodium for potassium in the gastrointestinal tract, increasing fecal excretion of potassium. Newer intestinal potassium binders like <strong>patiromer</strong> and ZS-9 are preferred due to their lack of intestinal toxicity. <strong>Hemodialysis</strong> is the <strong>most effective</strong> method to <strong>reduce plasma potassium concentration</strong>.</p>\n<p>In hypovolemic patients with oliguria, intravenous saline may be beneficial to improve distal delivery of sodium and enhancing renal potassium excretion. Loop and thiazide diuretics can be used in hypervolemic patients with sufficient renal function.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9281",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not seen in tumor lysis syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperphosphatemia"
        },
        {
          "id": 2,
          "text": "Hyperuricemia"
        },
        {
          "id": 3,
          "text": "Hypercalcemia"
        },
        {
          "id": 4,
          "text": "Hyperkalemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hypocalcemia,</strong>&nbsp;not hypercalcemia,<strong>&nbsp;</strong>is seen in <strong>tumor lysis syndrome</strong> (TLS).&nbsp;</p>\n<p>TLS is a potentially life-threatening condition characterized by the rapid <strong>destruction</strong> of a large number of <strong>tumor cells</strong>. The release of calcium <strong>phosphate</strong> from lysed cells contributes to <strong>hyperphosphatemia</strong> and subsequent <strong>reciprocal depression</strong> in serum <strong>calcium</strong> levels. The consumption of ionized calcium during the formation of calcium phosphate crystals leads to <strong>hypocalcemia</strong>.</p>\n<p>TLS is commonly observed after initiation of <strong>chemotherapy</strong> in hematologic malignancies characterized by high cell turnover rates, such as Burkitt's lymphoma and acute lymphoblastic leukemia.</p>\n<p>The destruction of neoplastic cells results in the release of nucleic acids, which are broken down into uric acid, leading to <strong>hyperuricemia</strong>. The acidic environment in the renal tubules can cause uric acid to precipitate, leading to <strong>acute renal failure</strong>.&nbsp;Potassium is released in large quantities during tumor cell lysis leading to <strong>hyperkalemia</strong>.&nbsp;</p>\n<p>TLS is diagnosed using the <strong>Cairo-Bishop</strong>&nbsp;criteria which includes both laboratory and clinical criteria.</p>\n<p>Prevention is the mainstay of the management of TLS, which involves includes <strong>allopurinol</strong>, which inhibits the production of uric acid, and <strong>aggressive hydration</strong> to promote urine flow. <strong>Urinary alkalization </strong>is <strong>not recommended</strong>.&nbsp; <strong>Febuxostat</strong>, a selective xanthine oxidase inhibitor, can be used as an alternative.</p>\n<p>In severe cases or when renal failure is present, <strong>rasburicase</strong>, a recombinant urate oxidase, is used for treatment. Rasburicase rapidly lowers uric acid levels by converting it into a highly soluble compound called allantoin. <strong>Renal replacement therapy</strong> is often required and should be considered in case of acute renal failure.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9298",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a negative acute phase reactant?",
      "choices": [
        {
          "id": 1,
          "text": "Albumin"
        },
        {
          "id": 2,
          "text": "Haptoglobin"
        },
        {
          "id": 3,
          "text": "Ferritin"
        },
        {
          "id": 4,
          "text": "C reactive protein"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Albumin is a negative acute phase reactant while haptoglobin, ferritin and C-reactive protein are positive acute phase reactants.</p>\n<p>Acute phase reactants are classified as positive and negative based on whether their levels decrease or increase in inflammatory states.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Acute phase reactants and their functions</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>\"Positive\" acute-phase proteins:</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Protein</strong></p>\n</td>\n<td>\n<p><strong>Immune system&nbsp;function</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>C-reactive protein</strong></p>\n</td>\n<td>\n<p>Opsonin&nbsp;on microbes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum amyloid P component</strong></p>\n</td>\n<td>\n<p>Opsonin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum amyloid A</strong></p>\n</td>\n<td>\n<p>Recruitment of immune cells to inflammatory sites</p>\n<p>Induction of enzymes that degrade extracellular matrix</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Complement factors</strong></p>\n</td>\n<td>\n<p>Opsonization, lysis, and clumping of target cells; Chemotaxis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mannan-binding lectin</strong></p>\n</td>\n<td>\n<p>Mannan-binding lectin pathway of complement activation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fibrinogen,&nbsp;prothrombin, factor VIII,<br />von Willebrand factor</strong></p>\n</td>\n<td>\n<p>Coagulation factors, trapping invading microbes in blood clots.<br />Some cause chemotaxis, Fibrinogen binds to red cells and induce rouleaux formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasminogen activator inhibitor-1 (PAI-1)</strong></p>\n</td>\n<td>\n<p>Prevents the degradation of blood clots by inhibiting plasminogen&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alpha 2-macroglobulin</strong></p>\n</td>\n<td>\n<p>Inhibitor of coagulation by inhibiting thrombin</p>\n<p>Inhibitor of fibrinolysis by inhibiting plasmin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ferritin</strong></p>\n</td>\n<td>\n<p>Binding iron, inhibiting microbe iron uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hepcidin</strong></p>\n</td>\n<td>\n<p>Stimulates the internalization of ferroportin, preventing release of iron bound by ferritin within intestinal enterocytes and macrophages</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ceruloplasmin</strong></p>\n</td>\n<td>\n<p>Oxidizes iron, facilitating for ferritin, inhibiting microbe iron uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Haptoglobin</strong></p>\n</td>\n<td>\n<p>Binds hemoglobin, inhibiting microbe iron uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Orosomucoid</strong><strong><br /> </strong><strong>(Alpha-1-acid glycoprotein, AGP)</strong></p>\n</td>\n<td>\n<p>Steroid carrier</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alpha 1-antitrypsin</strong></p>\n</td>\n<td>\n<p>Serpin, downregulates inflammation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alpha 1-antichymotrypsin</strong></p>\n</td>\n<td>\n<p>Serpin, downregulates inflammation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Thrombopoietin</strong></p>\n</td>\n<td>\n<p>Thrombocytosis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9393",
      "difficulty": "medium"
    },
    {
      "text": "A 3-month-old male child was brought with a history of fever and respiratory distress. Suspecting pneumonia, a chest X-ray was ordered. Which of the following is the most likely causative organism?",
      "choices": [
        {
          "id": 1,
          "text": "Klebsiella pneumoniae"
        },
        {
          "id": 2,
          "text": "Streptococcus pneumoniae"
        },
        {
          "id": 3,
          "text": "Mycoplasma pneumoniae"
        },
        {
          "id": 4,
          "text": "Staphylococcus aureus"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most likely causative agent of pneumonia in an <strong>infant</strong> with X-ray showing <strong>pneumatoceles</strong> (air-filled cysts within lung parenchyma) is&nbsp;<em><strong>Staphylococcus aureus</strong>.</em></p>\n<p>In <strong>newborns</strong> and <strong>infants</strong>, <em>S. aureus</em> is a significant cause of severe respiratory tract infections, presenting with dyspnea, fever, and respiratory failure. Community-acquired infections are often preceded by viral infections, most commonly influenza.&nbsp;Among adults, <strong>nosocomial</strong> <em>S. aureus</em> pulmonary infections are frequently observed in <strong>intubated patients</strong> within intensive care units.</p>\n<p><em>S. aureus</em> often causes <strong>necrotizing pneumonitis</strong> that may be associated with complications such as <strong>pneumothorax</strong> and <strong>empyema</strong>.</p>\n<p>Pneumatocoele can also be caused by&nbsp;<em>Streptococcus pneumoniae</em>,&nbsp;<em>Haemophilus influenzae</em>, <em>E. coli</em>,&nbsp;group A <em>streptococci</em>,&nbsp;<em>Klebsiella pneumoniae</em>, etc. However, Staphylococcus aureus is <strong>most commonly </strong>implicated.</p>\n<p>Other options:</p>\n<p>Option A: <strong><em>Klebsiella pneumoniae</em></strong>&nbsp;causes <strong>lobar pneumonia</strong>&nbsp;in <strong>alcoholics</strong> and diabetics. Patients present with&nbsp;fever, dyspnea, and a productive cough with&nbsp;<strong>red currant jelly sputum</strong>. Classic chest X-ray findings include <strong>upper lobe consolidation</strong>, classically on the <strong>right</strong> side, cavitation, and <strong>bulging fissure sign</strong>.</p>\n<p>The following image shows bulging fissure sign:&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/42665461a98c47d7902a285fe7dbff7cx1280x1497.JPEG\" alt=\"Explanation Image\"><p>Option B:&nbsp;<strong><em>Streptococcus pneumoniae&nbsp;</em></strong>causes <strong>lobar pneumonia</strong>.&nbsp;Patients with pneumococcal pneumonia present with fever, dyspnea, and <strong>productive cough</strong>. On examination, the involved lobes are <strong>dull</strong> to percussion, <strong>bronchial breath sounds</strong>, and crackles are heard on auscultation.&nbsp;</p>\n<p>The following image shows right lower lobe consolidation:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cafe42500b644382ad44f84bba9e324ax1280x1019.JPEG\" alt=\"Explanation Image\"><p>Option C:&nbsp;<em><strong>Mycoplasma pneumoniae&nbsp;</strong></em>causes&nbsp;<strong>atypical pneumonia</strong>. Patients present with&nbsp;<strong>dry cough</strong>, fever, chills, malaise, and upper respiratory tract symptoms. On auscultation, wheezes or rales are heard. Chest X-ray shows peribronchial pneumonia with prominent bronchial markings, interstitial infiltration, and atelectasis.</p>\n<p>The below chest X-ray shows patchy consolidation at the hilum and fanning to the periphery:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c11515d308804449887a93f28f2e9a68x1280x846.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/bc9666b426664523819231c585391200.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9394",
      "difficulty": "medium"
    },
    {
      "text": "What does the red cell distribution width deal with?",
      "choices": [
        {
          "id": 1,
          "text": "Hypochromia"
        },
        {
          "id": 2,
          "text": "Anisocytosis"
        },
        {
          "id": 3,
          "text": "Poikilocytosis"
        },
        {
          "id": 4,
          "text": "Anisochromia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Red cell distribution width</strong> (RDW) measures the <strong>range of red blood cell volumes</strong> and provides an assessment of their <strong>variability</strong> (anisocytosis).</p>\n<p>The <strong>normal</strong> range of RDW is <strong>11-14%</strong>. In the presence of uneven cell size (anisocytosis), the RDW increases to 15-18%.</p>\n<p>RDW has clinical utility in two main scenarios:</p>\n<ul>\n<li>In cases of <strong>microcytic anemia</strong> (low MCV), it helps <strong>differentiate</strong> between <strong>iron deficiency and thalassemia</strong>. Thalassemia is characterized by uniformly small red blood cells with a normal RDW, while iron deficiency leads to greater size variability and an increased RDW.&nbsp;</li>\n<li>A <strong>high RDW</strong> can indicate <strong>dimorphic anemia</strong> caused by chronic atrophic gastritis. Vitamin B12 malabsorption results in macrocytic anemia and blood loss leads to iron deficiency (microcytic anemia).&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9395",
      "difficulty": "easy"
    },
    {
      "text": "A 25-year-old woman came to the OPD one year after the birth of her last child. She had been treated for iron deficiency anemia while pregnant. On examination, she is pale and investigations show a Hb of 5g/dl and a reticulocyte count of 9%. What is her corrected reticulocyte count? (Take normal Hb as 15g/dl)",
      "choices": [
        {
          "id": 1,
          "text": "6"
        },
        {
          "id": 2,
          "text": "4.5"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The corrected reticulocyte count (CRC) of this patient is <strong>3</strong>.</p>\n<p><strong>CRC = Reticulocyte % &nbsp;x &nbsp;(Actual Hb / Normal Hb)</strong></p>\n<blockquote>\n<div>Plugging in the values given in the question,</div>\n<div>CRC = 9% x 5/15 = 3%</div>\n</blockquote>\n<div>Alternatively, CRC can be calculated using hematocrit (PCV) as follows:</div>\n<div><strong>CRC = Reticulocyte % &nbsp;x &nbsp;(Actual PCV / Normal PCV)</strong></div>\n<p>For these calculations, take normal Hb as 15g/dL and normal PCV as 45%.</p>\n<p>The patient's hemoglobin level (5 g/dL) is significantly lower than the normal hemoglobin level (15 g/dL). To obtain an accurate assessment of <strong>reticulocyte</strong> production <strong>relative to</strong> the reduced number of circulating <strong>red blood cells</strong>, a correction factor has to be applied. CRC accounts for the anemia and provides a more precise estimate of the reticulocyte count.</p>\n<p>When&nbsp;<strong>polychromatophilic macrocytes&nbsp;</strong>(<strong>prematurely released</strong> reticulocytes/<strong>shift cells</strong>) are observed in the peripheral blood smear, a second <strong>correction</strong> is applied to account for the&nbsp;<strong>longer life of reticulocytes&nbsp;</strong>to yield&nbsp;<strong>reticulocyte production index </strong>(RPI).&nbsp;</p>\n<p>In the classification of anemia, the patient's reticulocyte count is compared to the expected reticulocyte response.&nbsp;Reticulocytes can be identified by staining their <strong>ribosomal RNA</strong> with a <strong>supravital dye</strong>, resulting in the formation of blue or black punctate spots. They can be quantified manually or by using fluorescent dyes. The presence of reticulocytes indicates <strong>active red cell production</strong>.</p>\n<p>The premature release of <strong>reticulocytes</strong> is typically associated with <strong>increased EPO</strong> stimulation.&nbsp;In <strong>hemolytic anemia</strong>, red cell production can <strong>increase</strong> six to seven times. If the <strong>RPI &lt; 2</strong> in a patient with anemia, a <strong>defect in erythroid marrow</strong> proliferation or <strong>maturation</strong> has to be suspected.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9396",
      "difficulty": "medium"
    },
    {
      "text": "A 44-year-old man is referred to your center for management of severe hyperglycemia. During examination, you note that the patient has enlarged feet, coarse facial features and prognathism. You suspect acromegaly. Which of the following tests can you use as a screening method for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Oral glucose challenge test with GH level"
        },
        {
          "id": 2,
          "text": "Insulin-like growth factor-1 binding protein-3 (IGFBP-3) level"
        },
        {
          "id": 3,
          "text": "Insulin like growth factor-1 levels"
        },
        {
          "id": 4,
          "text": "Random growth hormone levels"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The best <strong>screening test</strong> for <strong>acromegaly</strong> is the measurement of serum insulin-like growth factor-1 (<strong>IGF-1</strong>) level.</p>\n<p>Other options:</p>\n<p>Options A and B: <strong>Oral glucose challenge test with growth hormone (GH) levels</strong>&nbsp;is used for further <strong>confirmation</strong> of the diagnosis. Increased insulin-like growth factor-1 binding protein-3 (<strong>IGFBP-3</strong>) levels can also be seen in patients with acromegaly. But they are not typically used as initial screening methods.</p>\n<p>Option D:&nbsp;IGF-1 levels are more reliable than <strong>random GH levels</strong> because GH secretion is <strong>pulsatile</strong>. IGF-1 levels reflect long-term exposure to GH and provide a more stable indicator of excessive GH production.</p>\n<p>Acromegaly is characterized by excessive GH secretion, usually caused by a <strong>somatotrope adenoma</strong> in the pituitary gland. It can also be due to <strong>ectopic GH</strong> secretion or <strong>hypothalamic tumors</strong>.</p>\n<p>The clinical presentation of acromegaly includes <strong>frontal bossing</strong>, increased hand and foot size, coarse facial features, <strong>mandibular prognathism</strong>,&nbsp;<strong>widened space between lower incisors</strong>&nbsp;and other manifestations such as soft tissue swelling, deepening voice, <strong>carpal tunnel syndrome</strong>, arthropathy, and <strong>acanthosis nigricans</strong>.</p>\n<p>It can also lead to <strong>cardiovascular</strong> complications (<strong>cardiomyopathy</strong>, left ventricular hypertrophy, and <strong>hypertension</strong>), <strong>obstructive sleep apnea</strong>, <strong>diabetes mellitus</strong>, an increased risk of colon polyps, and&nbsp;<strong>colonic malignancy</strong>.&nbsp;</p>\n<p>The primary treatment for acromegaly is <strong>surgical resection</strong> of GH-secreting adenomas. <strong>Somatostatin receptor ligands</strong> like octreotide and lanreotide, which suppress GH and IGF-1 levels, are used as adjuvant treatment or when surgery is not possible or unsuccessful. Radiation therapy may be considered for patients who cannot tolerate or do not respond to medical therapy. Other treatment options include <strong>GH receptor antagonists</strong> like <strong>pegvisomant</strong> and dopamine agonists like cabergoline.</p><hr><h3>Related Pearl: Tests for Acromegaly</h3><p><strong>Screening test</strong>:</p>\n<p>The <strong>single</strong>&nbsp;best test for the diagnosis of acromegaly is the measurement of serum insulin-like growth factor-1 (<strong>IGF-1</strong>). A normal serum IGF-1 concentration is strong evidence that the patient does&nbsp;<strong>not</strong>&nbsp;have acromegaly.</p>\n<p><strong>Confirmatory test</strong>:</p>\n<p>GH suppression test:<strong>&nbsp;75 g</strong> of <strong>oral glucose</strong> (OGTT- oral glucose tolerance test) is administered to the patient. Blood GH levels are checked at 30, 60, 90, 120 min (i.e over 2 hours) after the glucose load.&nbsp;Normally, glucose suppresses GH and it falls to &lt;1 ng/mL. If GH <strong>&gt;1 ng/mL</strong>, it is diagnostic of acromegaly.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9399",
      "difficulty": "easy"
    },
    {
      "text": "What is not a feature of myasthenia gravis among the following?",
      "choices": [
        {
          "id": 1,
          "text": "Muscle fatigue"
        },
        {
          "id": 2,
          "text": "Absent deep tendon reflexes"
        },
        {
          "id": 3,
          "text": "Normal pupillary reflex"
        },
        {
          "id": 4,
          "text": "Ptosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Absent deep tendon reflex</strong> is <strong>not a feature</strong> of myasthenia gravis (MG).&nbsp;</p>\n<p>MG usually occurs in <strong>young females</strong>. Patients usually present with <strong>weakness</strong> and fatiguability of the muscles, which <strong>worsens</strong> on <strong>repeated use</strong> or late in the day and improves on rest. The cranial muscles, particularly the eyelids and extraocular muscles are involved early in the course of MG. <strong>Diplopia</strong> and <strong>ptosis</strong> are common initial complaints. When MG becomes generalized, the <strong>proximal muscles</strong> of the limbs are affected first. Despite the muscle weakness, the <strong>deep tendon reflexes remain normal</strong>. <strong>Snarling</strong> expression on smiling (facial weakness), <strong>nasal timbre</strong> of speech (weakness of palate and tongue), and difficulty swallowing may be seen.&nbsp;<strong>Bulbar weakness</strong> and <strong>respiratory depression</strong> are seen more frequently in <strong>MuSK antibody&ndash;positive MG</strong>.</p>\n<p>MG is an <strong>autoimmune</strong> disorder most commonly caused by <strong>antibodies</strong> against the <strong>acetylcholine receptor</strong> (AChR). These antibodies cause damage to the postsynaptic muscle membrane and increased endocytosis of the AChR. This autoimmune response against the AChR seems to be mediated by the <strong>thymus</strong>. The myoid (muscle-like) cells present in the thymus express AChRs on their surface and are postulated to provide the autoantigen which triggers this autoimmune reaction. <strong>Thymic hyperplasia</strong> is seen in 65% of the patients, and <strong>thymomas</strong> are seen in 10% of the patients.</p>\n<p>The tests which are used to confirm the diagnosis of MG include:</p>\n<ul>\n<li><strong>Anti-AChR antibody</strong> immunoassay: 85% of myasthenic patients have detectable anti-AChR antibodies, but only 50% of patients with weakness limited to ocular muscles. The presence of anti-AChR antibodies is highly suggestive of MG, but a <strong>negative test does not exclude the disease</strong>. Antibodies to <strong>MuSK</strong> and <strong>LRP4</strong> are found in some patients</li>\n<li><strong>Recurrent nerve stimulation tes</strong>t: MG shows a <strong>decremental response &gt; 10%</strong>, while Lambert-Eaton myasthenic syndrome (LEMS) shows an incremental response</li>\n<li>Block and jitter response on <strong>single-fiber electromyography</strong></li>\n<li><strong>Positive edrophonium test</strong>: improvement of ptosis on the administration of anticholinesterase such as edrophonium</li>\n<li><strong>Positive ice-pack test</strong>: improvement of ptosis on the application of ice-pack on the affected eye</li>\n</ul>\n<p>The first line of medical management in MG is anticholinesterase drugs. <strong>Pyridostigmine&nbsp;</strong>30&ndash;60 mg three to four times daily is the most commonly used drug.</p>\n<p>Patients are&nbsp;<strong>evaluated</strong>&nbsp;<strong>for</strong>&nbsp;associated&nbsp;<strong>thymic abnormalities</strong>&nbsp;using a&nbsp;<strong>CT chest</strong>.&nbsp;<strong>Thymectomy&nbsp;</strong>is considered in patients with&nbsp;<strong>thymoma </strong>and in&nbsp;<strong>g</strong><strong>eneralized MG </strong>patients&nbsp;with<strong> anti-AChR antibodies</strong>.</p>\n<p><strong>Immunotherapy therapy</strong> can be initiated in patients with poor control on pyridostigmine after thymectomy.&nbsp;<strong>Glucocorticoids</strong>, <strong>cyclosporine</strong>, or <strong>tacrolimus</strong> are generally effective within 1-3 months. <strong>Azathioprine</strong> and <strong>mycophenolate mofetil</strong> may take several months to show beneficial effects and are used for the <strong>long-term management</strong> of MG. <strong>Rituximab</strong> has shown effectiveness in patients with MuSK antibodies. Intravenous <strong>eculizumab</strong>, which binds to<strong>&nbsp;</strong>terminal complement <strong>component</strong> 5, is also effective.</p>\n<p>Myasthenic crisis is the life-threatening exacerbation of MG leading to respiratory failure. Treatment for myasthenic crisis should take place in <strong>intensive care units</strong>.&nbsp;It is important to <strong>rule out excessive anticholinesterase medication</strong> as a cause of deterioration by temporarily discontinuing these drugs.&nbsp;<strong>Plasmapheresis</strong> and intravenous immunoglobulin (<strong>IVIg</strong>) are beneficial in hastening recovery.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9400",
      "difficulty": "easy"
    },
    {
      "text": "Regarding the procedure done with the needle shown below, which of the following is false?",
      "choices": [
        {
          "id": 1,
          "text": "To be done in lateral recumbent position"
        },
        {
          "id": 2,
          "text": "Breath holding is not necessary"
        },
        {
          "id": 3,
          "text": "The bevel should face upwards while inserting the needle"
        },
        {
          "id": 4,
          "text": "Coagulopathy is not a contraindication"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given image shows a&nbsp;<strong>Quincke-type lumbar puncture needle</strong>. Coagulopathy is a contraindication to perform lumbar puncture (LP).</p>\n<p><strong>Contraindications</strong> for LP include:</p>\n<ul>\n<li>Patients receiving <strong>anticoagulant</strong> or <strong>antiplatelet</strong> medications and those with <strong>coagulation defects</strong></li>\n<li>Possible raised <strong>intracranial pressure</strong></li>\n<li>Suspected spinal epidural abscess</li>\n<li><strong>Infection</strong> at the site of puncture</li>\n</ul>\n<p>Before performing an LP, it is important to assess the patient's bleeding risk by checking their <strong>platelet count</strong>, international normalized ratio (<strong>INR</strong>), and partial thromboplastin time (<strong>PTT</strong>). LP is considered <strong>contraindicated</strong> if the <strong>platelet count</strong> is <strong>less than 20,000/&mu;L</strong>, and some institutions recommend a platelet count of greater than 40,000/&mu;L before proceeding with the procedure.</p>\n<p><strong>Proper positioning</strong> of the patient is crucial for an LP. The patient should lie on their side away from the examiner, with their knees bent and pulled up toward the abdomen (<strong>lateral decubitus</strong>). The neck should be gently bent forward, and the shoulders and pelvis should be aligned vertically. LP is typically performed at or below the <strong>L3-L4 interspace</strong>, which can be identified by palpating the spinous processes and using a line drawn between the <strong>posterior superior iliac crests</strong> as a guide.</p>\n<p>Alternatively, the LP can be done with the patient seated <strong>upright</strong>, leaning forward to flex the back. This position is suitable for obese patients.</p>\n<p>After <strong>sterile preparation</strong> of the insertion site and the injection of a <strong>local anesthetic,</strong>&nbsp;the LP needle is inserted midline between two spinous processes, with the bevel parallel to the dural fibers <strong>facing upwards</strong>. The needle is advanced until the <strong>subarachnoid space</strong> (SAS) is reached indicated by a <strong>loss of resistance</strong>. Once the SAS is reached, the opening pressure is measured, and CSF is allowed to drip into collection tubes for analysis.</p>\n<p>A <strong>traumatic tap</strong>&nbsp;may cause a bloody tap, which can be differentiated from <strong>subarachnoid hemorrhage</strong> (SAH) by examining the supernatant after centrifugation. Prior to needle removal, the <strong>stylet is reinserted</strong> to prevent nerve entrapment and the development of a dural CSF leak. There is <strong>no need for prolonged recumbency</strong> after the procedure to prevent post-LP headache.</p>\n<p><strong>Neuroimaging</strong> is recommended before performing an LP in patients who have an <strong>altered level of consciousness</strong>, <strong>focal neurological deficits</strong>, new-onset <strong>seizures</strong>, or <strong>papilledema</strong>. This is because these patients are at a higher risk of developing cerebellar or tentorial <strong>herniation</strong>, a rare but potentially fatal complication. Imaging studies should also include the spine in patients with symptoms suggestive of <strong>spinal cord compression</strong>, such as back pain, leg weakness, urinary retention, or incontinence. In cases where <strong>acute meningitis</strong> is suspected and neuroimaging is necessary before the LP, it is recommended to administer <strong>antibiotics,</strong>&nbsp;preferably <strong>after blood culture</strong>,&nbsp;<strong>before</strong> conducting the <strong>imaging</strong> study.</p>\n<p>The image below shows Quincke (dura cutting) and Whitacre (dura splitting) LP needles:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1e2a8a04d9b9497cbe17eec8daf36f9fx1280x1233.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/33a693f2955e4f5281c12b0deac01e52.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9402",
      "difficulty": "easy"
    },
    {
      "text": "Pancreatic cancer has the highest association with _______.",
      "choices": [
        {
          "id": 1,
          "text": "FAMMM syndrome"
        },
        {
          "id": 2,
          "text": "FAP"
        },
        {
          "id": 3,
          "text": "Hereditary pancreatitis"
        },
        {
          "id": 4,
          "text": "Peutz-Jeghers syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Pancreatic cancer</strong> has the highest association with <strong>Peutz&ndash;Jeghers syndrome.</strong></p>\n<p>The risk factors for pancreatic cancer include:</p>\n<ul>\n<li><strong>Smoking</strong>: One to threefold increase in risk</li>\n<li>Chronic pancreatitis</li>\n<li>Occupational exposure</li>\n<li><strong>Obesity</strong>: Up to threefold increase in risk</li>\n<li><strong>New-onset diabetes </strong>associated with:\n<ul>\n<li>Elderly patients</li>\n<li>Lower body mass index</li>\n<li>Weight loss</li>\n<li>No family history of diabetes</li>\n</ul>\n</li>\n<li>Hereditary factors:<br />\n<table>\n<tbody>\n<tr>\n<td><strong>Syndrome</strong></td>\n<td><strong>Germ-line mutation</strong></td>\n<td>\n<p class=\"p1\"><strong>Estimated increased risk (fold) of</strong></p>\n</td>\n</tr>\n<tr>\n<td>Familial adenomatous polyposis</td>\n<td>&nbsp;APC</td>\n<td>4</td>\n</tr>\n<tr>\n<td>HNPCC /Lynch&nbsp;syndrome</td>\n<td>MLH1, MSH2, MSH6, PMS2&nbsp;</td>\n<td>8</td>\n</tr>\n<tr>\n<td>Hereditary breast and ovarian cancer</td>\n<td>BRCA 2&nbsp;</td>\n<td>10&nbsp;</td>\n</tr>\n<tr>\n<td>Familial pancreatic cancer</td>\n<td>&nbsp;</td>\n<td>18</td>\n</tr>\n<tr>\n<td>FAMMM&nbsp;syndrome</td>\n<td>&nbsp;p16/CDKN2A&nbsp;</td>\n<td>20&nbsp;</td>\n</tr>\n<tr>\n<td>Cystic fibrosis</td>\n<td>CFTR&nbsp;</td>\n<td>30</td>\n</tr>\n<tr>\n<td>Hereditary pancreatitis</td>\n<td>PRSS 1/SPINK1</td>\n<td>53</td>\n</tr>\n<tr>\n<td><strong>Peutz&ndash;Jeghers syndrome</strong></td>\n<td>STKII (LKB1)</td>\n<td><strong>~132&nbsp;</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</li>\n</ul>\n<div>FAMMM: Familial atypical multiple mole melanoma</div>\n<div>HNPCC: Hereditary nonpolyposis colorectal cancer&nbsp;</div><hr><h3>Related Pearl: Cancer Predisposition Syndromes and Associated Genes</h3><table>\n<tbody>\n<tr>\n<td><strong>Syndrome </strong></td>\n<td><strong>Gene</strong></td>\n<td><strong>Chromosome</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Tumors</strong></td>\n</tr>\n<tr>\n<td>Ataxia telangiectasia</td>\n<td>ATM</td>\n<td>11q22-q23</td>\n<td>AR</td>\n<td>Breast</td>\n</tr>\n<tr>\n<td>Bloom syndrome</td>\n<td>BLM</td>\n<td>15q26.1</td>\n<td>AR</td>\n<td>Several types</td>\n</tr>\n<tr>\n<td>Cowden syndrome</td>\n<td>PTEN</td>\n<td>10q23</td>\n<td>AD</td>\n<td>Breast, thyroid</td>\n</tr>\n<tr>\n<td>Autoimmune lymphoproliferative syndrome</td>\n<td>FASFASL&nbsp;</td>\n<td>10q24 1q23</td>\n<td>AD</td>\n<td>Lymphomas</td>\n</tr>\n<tr>\n<td>Familial adenomatous polyposis&nbsp;</td>\n<td>APC</td>\n<td>5q21</td>\n<td>AD</td>\n<td>Intestinal adenoma, colorectal</td>\n</tr>\n<tr>\n<td>Familial melanoma 1</td>\n<td>p16INK4</td>\n<td>9p2</td>\n<td>AD</td>\n<td>Melanoma, pancreatic</td>\n</tr>\n<tr>\n<td>Familial Wilms&rsquo; tumor</td>\n<td>WT1</td>\n<td>11p13</td>\n<td>AD</td>\n<td>Kidney (pediatric)</td>\n</tr>\n<tr>\n<td>Hereditary breast/ovarian cancer &nbsp;</td>\n<td>BRCA1BRCA2&nbsp;</td>\n<td>17q2113q12.3&nbsp;</td>\n<td>AD</td>\n<td>Breast, ovarian, colon, prostate</td>\n</tr>\n<tr>\n<td>Hereditary diffuse gastric cancer</td>\n<td>CDH1</td>\n<td>16q22</td>\n<td>AD</td>\n<td>Stomach</td>\n</tr>\n<tr>\n<td>Hereditary multiple exostoses</td>\n<td>EXT1EXT2&nbsp;</td>\n<td>8q2411p11-12&nbsp;</td>\n<td>AD</td>\n<td>Exostoses, chondrosarcoma</td>\n</tr>\n<tr>\n<td>Hereditary prostate cancer</td>\n<td>HPC1</td>\n<td>1q24-25</td>\n<td>AD</td>\n<td>Prostate</td>\n</tr>\n<tr>\n<td>Hereditary retinoblastoma</td>\n<td>RB1</td>\n<td>13q14.2</td>\n<td>AD</td>\n<td>Retinoblastoma, osteosarcoma</td>\n</tr>\n<tr>\n<td>Hereditary nonpolyposis colon cancer (HNPCC)&nbsp;</td>\n<td>MSH2MLH1MSH6PMS2&nbsp;</td>\n<td>2p163p21.32p167p22&nbsp;</td>\n<td>AD</td>\n<td>Colon, endometrial, ovarian, stomach, smallbowel, ureter carcinoma</td>\n</tr>\n<tr>\n<td>Hereditary papillary renal carcinoma&nbsp;</td>\n<td>MET</td>\n<td>7q31</td>\n<td>AD</td>\n<td>Papillary kidney</td>\n</tr>\n<tr>\n<td>Juvenile polyposis&nbsp;</td>\n<td>SMAD4</td>\n<td>18q21</td>\n<td>AD</td>\n<td>Gastrointestinal, pancreatic</td>\n</tr>\n<tr>\n<td>Li-Fraumeni</td>\n<td>TP53</td>\n<td>17p13.1</td>\n<td>AD</td>\n<td>Sarcoma, breast</td>\n</tr>\n<tr>\n<td>Multiple endocrine neoplasia type 1</td>\n<td>MEN1</td>\n<td>11q13</td>\n<td>AD</td>\n<td>Parathyroid, endocrine, pancreas, and pituitary</td>\n</tr>\n<tr>\n<td>Multiple endocrine neoplasia type 2a &nbsp;</td>\n<td>RET</td>\n<td>10q11.2</td>\n<td>AD</td>\n<td>Medullary thyroid carcinoma,pheochromocytoma</td>\n</tr>\n<tr>\n<td>Neurofibromatosis type 1 &nbsp;</td>\n<td>NF1</td>\n<td>17q11.2</td>\n<td>AD</td>\n<td>Neurofibroma, neurofibrosarcoma, brain</td>\n</tr>\n<tr>\n<td>Neurofibromatosis type 2</td>\n<td>NF2</td>\n<td>22q12.2</td>\n<td>AD</td>\n<td>Vestibular schwannoma, meningioma, spine</td>\n</tr>\n<tr>\n<td>Nevoid basal cell carcinoma syndrome(Gorlin&rsquo;s syndrome)&nbsp;</td>\n<td>PTCH</td>\n<td>9q22.3</td>\n<td>AD</td>\n<td>Basal cell carcinoma, medulloblastoma,jaw cysts&nbsp;</td>\n</tr>\n<tr>\n<td>Tuberous sclerosis</td>\n<td>TSC1TSC2&nbsp;</td>\n<td>9q3416p13.3&nbsp;</td>\n<td>AD</td>\n<td>Angiofibroma, renal angiomyolipoma&nbsp;</td>\n</tr>\n<tr>\n<td>von Hippel&ndash;Lindau</td>\n<td>VHL</td>\n<td>3p25-26</td>\n<td>AD</td>\n<td>Kidney, cerebellum, pheochromocytoma</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9404",
      "difficulty": "medium"
    },
    {
      "text": "The flow-volume curve after spirometry in patient 1 is given below. The most likely diagnosis in this patient is:",
      "choices": [
        {
          "id": 1,
          "text": "Endobronchial neoplasm"
        },
        {
          "id": 2,
          "text": "Bronchial Asthma"
        },
        {
          "id": 3,
          "text": "Myasthenia gravis"
        },
        {
          "id": 4,
          "text": "Emphysema"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given <strong>flow-volume curve</strong>&nbsp;shows <strong>decreased</strong> <strong>lung volumes </strong>(total lung capacity, vital capacity, and residual volume) with <strong>normal shape</strong>, suggestive of a <strong>restrictive pattern</strong>.&nbsp;The curve is a miniature version of the normal curve with shift towards the <strong>right</strong>. It is seen in&nbsp;<strong>m</strong><strong>yasthenia gravis</strong>.</p>\n<p>Myasthenia gravis presents with&nbsp;<strong>ventilatory restriction</strong>&nbsp;due to reduced respiratory muscle strength.</p>\n<p>Asthma, emphysema, and endobronchial neoplasms present with&nbsp;<strong>obstructive flow patterns</strong>.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/44860c0f326f4ddb85d654120aa8c23cx1280x1455.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Flow-volume graph/Loop</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0d448a20301a4373b39e03a726675434x1280x3207.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: PFT for obstructive vs restrictive diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>PFT</strong></p>\n</td>\n<td>\n<p><strong>Obstructive disease</strong></p>\n</td>\n<td>\n<p><strong>Restrictive disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FVC</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FEV1</p>\n</td>\n<td>\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td>\n<p>FEV1% (FEV1/FVC)</p>\n</td>\n<td>\n<p>Decreased (&lt;0.7)</p>\n</td>\n<td>\n<p>Normal/ increased (&gt;0.7)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FEF 25-75</p>\n</td>\n<td>\n<p>&lt;50% predicted</p>\n</td>\n<td>\n<p>Normal/ decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>TLC</p>\n</td>\n<td>\n<p>Normal/ increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>RV</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>DLCO</p>\n</td>\n<td>\n<ul>\n<li>Normal or increased in asthma</li>\n<li>Decreased in emphysema</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Decreased in intrinsic restrictive disease</li>\n<li>Normal in neuromuscular or musculoskeletal restrictive disease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>FVC: Forced Vital Capacity</p>\n<p>FEV1: Forced expiratory volume in 1 second</p>\n<p>FEF 25-75: Forced expiratory flow at 25-75% vital capacity</p>\n<p>TLC: Total lung capacity</p>\n<p>RV: Residual volume</p>\n<p>DLCO: Diffusion capacity of lung for Carbon monoxide.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/aadd41bdc3854fbcb8da997cee5ca6b5.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9410",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old female patient has NYHA class III heart failure with dyspnea, pedal edema and K+ levels of 5.5 mg% and creatinine 1.1 mg%. Which of the following drugs can be used in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Digoxin"
        },
        {
          "id": 2,
          "text": "Spironolactone"
        },
        {
          "id": 3,
          "text": "Enalapril"
        },
        {
          "id": 4,
          "text": "Furosemide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical scenario describes a patient with <strong>symptomatic heart failure</strong> and&nbsp;<strong>K<sup>+ </sup>levels of 5.5 mg%</strong>. She requires a diuretic for symptom control. <strong>Furosemide&nbsp;</strong>can be given safely as it causes <strong>hypokalemia.</strong></p>\n<p>Other options:</p>\n<p>Option A:&nbsp;<strong>Digoxin</strong> is not used as a first-line drug in the management of symptomatic heart failure.</p>\n<p>Options B and C:&nbsp;<strong>Spironolactone</strong> (K<sup>+ </sup>sparing diuretic) and <strong>enalapril</strong> (ACE inhibitor) can cause hyperkalemia.&nbsp;&nbsp;</p>\n<p>The first step in managing acute decompensated heart failure (ADHF) is addressing the factors that caused the decompensation. They include&nbsp;<strong>nonadherence</strong> to medications, dietary indiscretion, medication use that exacerbates heart failure, <strong>coronary ischemia</strong>, <strong>arrhythmias</strong>, valvular heart disease, <strong>infection</strong>, and pulmonary <strong>thromboembolism</strong>.</p>\n<p><strong>Volume management</strong> is crucial in ADHF. Intravenous <strong>loop diuretics</strong> are used to relieve congestion. The effectiveness of diuretic therapy can be assessed by changes in weight, improvement in symptoms, and clinical examination findings. <strong>Natriuretic peptide</strong> levels can also help assess the adequacy of therapy and predict risk.</p>\n<p><strong>Cardiorenal syndrome</strong>, characterized by the interplay between heart and kidney dysfunction, is a common complication of ADHF. Diuretic therapy should be carefully managed to avoid worsening renal function in patients with elevated right-sided filling pressures. In cases of severe low cardiac output, inotropic therapy or mechanical circulatory support may be necessary to preserve or improve renal function temporarily.</p>\n<p><strong>Vasodilators</strong> like nitroglycerin, sodium nitroprusside, and <strong>nesiritide&nbsp;</strong>(recombinant BNP) are used to reduce filling pressures and systemic vascular resistance.&nbsp;</p>\n<p><strong>Inotropic therapy</strong> with drugs like <strong>dopamine</strong> and <strong>milrinone</strong> is used to increase myocardial contractility and improve cardiac output in patients with <strong>low-output</strong> ADHF. Dopamine has dose-dependent effects on different receptors, while milrinone is a phosphodiesterase-3 inhibitor.</p><hr><h3>Related Pearl: Drugs used in heart failure</h3><div>Drugs used in<strong> acute decompensated heart failure:</strong></div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Intravenous vasodilators</strong></td>\n</tr>\n<tr>\n<td>\n<p>Nitroglycerine</p>\n<p>Sodium nitroprusside</p>\n</td>\n<td>Decrease preload and afterload</td>\n</tr>\n<tr>\n<td>Nesiritide</td>\n<td>Recombinant human BNP</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Intravenous positive inotropes</strong></td>\n</tr>\n<tr>\n<td>\n<p>Dobutamine</p>\n<p>Dopamine</p>\n<p>Epinephrine</p>\n<p>Norepinephrine</p>\n</td>\n<td>&beta;1 receptor-mediated stimulation of cardiac output</td>\n</tr>\n<tr>\n<td>\n<p>Enoximone</p>\n<p>Milrinone</p>\n</td>\n<td>PDE 3/4 inhibitors</td>\n</tr>\n<tr>\n<td>\n<p>Levosimendan</p>\n<p>Pimobendan</p>\n</td>\n<td>Combined Ca<sup>2+</sup> sensitizers and PDE3 inhibitors</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Drugs used for rapid symptom relief</strong></td>\n</tr>\n<tr>\n<td>\n<p>Bumetanide</p>\n<p>Furosemide</p>\n<p>Torasemide</p>\n</td>\n<td>Loop diuretics- used for symptomatic treatment of severe heart failure and acute decompensation.</td>\n</tr>\n<tr>\n<td>Morphine</td>\n<td>Opioid - to calm the patient and decreases cardiac O2 consumption</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>\n<div>Drugs used in<strong> chronic heart failure:</strong></div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td>ACE inhibitors</td>\n<td>Used as first-line therapy</td>\n</tr>\n<tr>\n<td>ARBs</td>\n<td>Used in case of intolerance to ACE inhibitors</td>\n</tr>\n<tr>\n<td>Beta-blockers</td>\n<td>Used as first-line therapy &nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Spironolactone</p>\n<p>Eplerenone</p>\n</td>\n<td>Mineralocorticoid receptor antagonists - first-line drugs for symptomatic heart failure.</td>\n</tr>\n<tr>\n<td>SGLT-2 inhibitors</td>\n<td>Used as 1st line therapy- reduces mortality and morbidity</td>\n</tr>\n<tr>\n<td>Sacubitril/Valsartan</td>\n<td>Neprilysin inhibitor/ARB(ARNI)</td>\n</tr>\n<tr>\n<td>Ivabradine</td>\n<td>Inhibitor of I<sub>f</sub>&nbsp;current in the sinoatrial node</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9413",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following features of stroke need not be treated?",
      "choices": [
        {
          "id": 1,
          "text": "Dysphagia"
        },
        {
          "id": 2,
          "text": "Spasticity"
        },
        {
          "id": 3,
          "text": "Fever"
        },
        {
          "id": 4,
          "text": "Neglect"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Neglect</strong> is a feature of stroke that <strong>need not be treated</strong>. Although neglect indicates a poor prognosis, most patients recover without any treatment in 1-6 months.</p>\n<p><strong>Dysphagia</strong>(Option A) poses a high risk of <strong>aspiration</strong> and hence can't be left untreated. <strong>Spasticity</strong>(Option B) can be treated with baclofen, tizanidine. Untreated, it creates a <strong>psychosocial impact</strong> on the patient. <strong>Fever</strong>(Option C) is deleterious in stroke patients and must be treated.</p>\n<p><strong>Neglect</strong>&nbsp;can arise from injury to <strong>cortical-limbic-reticular network</strong>, that directs attention and integrates the localization and identification of a stimulus. Neglect is&nbsp; associated with poor&nbsp;scores and slower recovery, but severe neglect is rare beyond 6 months.&nbsp;<strong>Recovery</strong> is <strong>rapid</strong> in the first 2 weeks, regardless of the side of stroke. By 3 months, patients might have some residual visual neglect.&nbsp;The choice of an intervention depends on the mechanism of neglect, the patient can be treated for an underaroused right hemisphere which has difficulty processing sensory inputs.&nbsp;</p>\n<p><strong>Neurogenic dysphagia</strong> is an important cause of <strong>pulmonary infection</strong> in any patient with stroke, motor neuron disease, even transient dysphagia can lead to malnutrition, dehydration, aspiration pneumonia, and airway obstruction with asphyxia, it increases the risk of death and institutionalization.&nbsp;Early placement of&nbsp; nasogastric tube to feed patients after stroke has improved nutrition and reduced deaths.</p>\n<p><strong>Spasticity&nbsp;</strong>is seen in less than 20% of stroke patients. Patients with bilateral weakness from hypoxic injury are likely to have signs of spasticity.&nbsp;Exaggerated cutaneous and autonomic reflexes and involuntary spasms are disabling problems associated with spasticity. Physical modalities like slow stretching movements and daily passive exercises will reduce symptoms of spasticity and risk of contractures. Baclofen, tizanidine, and clonidine are used in reducing clonus and extensor spasms.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9416",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old man is brought to the emergency following an episode of syncope during his morning walk. His blood pressure is 80/60 mm Hg. He has a history of myocardial infarction 5 yrs back. His present ECG is given below. Which is the most appropriate treatment for the patient?",
      "choices": [
        {
          "id": 1,
          "text": "Lignocaine"
        },
        {
          "id": 2,
          "text": "Diazoxine"
        },
        {
          "id": 3,
          "text": "DC cardioversion"
        },
        {
          "id": 4,
          "text": "Lidocaine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario describes a man with history of <strong>coronary artery disease</strong> developing <strong>syncope.&nbsp;</strong>The ECG shows&nbsp;<strong>wide QRS complex </strong>(&gt; 0.12 s)&nbsp;tachycardia with a single QRS morphology suggestive of monomorphic&nbsp;<strong>ventricular tachycardia (VT)</strong>. The most appropriate treatment of VT in a <strong>hemodynamically unstable</strong> (systolic blood pressure &lt; 90 mm Hg) patient is&nbsp;<strong>DC cardioversion</strong>.</p>\n<p>VT can be casued by structural heart disease, scar-related reentry, cardiomyopathies, or abnormalities in the conduction pathways. VT is said to be <strong>sustained</strong> if it lasts for at least <strong>30 seconds</strong> or requires intervention for <strong>termination</strong>.</p>\n<p>Rapid VT can lead to <strong>hypotension</strong> and <strong>syncope</strong>, especially in patients with ventricular dysfunction. Patients with normal cardiac function may tolerate sustained VT, presenting with <strong>palpitations</strong>. Monomorphic VT associated with structural heart disease can progress to <strong>ventricular fibrillation</strong> (VF) and <strong>sudden cardiac arrest</strong>.</p>\n<p><strong>QRS synchronous electrical cardioversion</strong> is performed for <strong>unstable</strong> patients. Intravenous <strong>amiodarone</strong> is the preferred drug for <strong>stable</strong> VT associated with heart disease.</p>\n<p>After restoring sinus rhythm, further evaluation is necessary to determine the underlying heart disease. Treatment options include antiarrhythmic medications, <strong>catheter ablation</strong>, or implantable cardioverter-defibrillators (<strong>ICDs</strong>) for recurrent or high-risk VT. ICDs are commonly used for secondary prevention of sudden death in patients with sustained VT and structural heart disease.</p><hr><h3>Related Pearl: ECG patterns of various ventricular arrhythmias</h3><p>Ventricular tachycardia</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/097b95729fa14ac68da475ce6288a968x1088x570.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Polymorphic ventricular tachycardia associated with QTc prolongation- Torsades de pointes</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8ebe0b5757c4efca4f5dd15c6d24e99x1268x324.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Ventricular flutter</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/666962cd0f424000b7e84123f719f120x502x282.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Ventricular fibrillation</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/25067efa869941baa6a40b54599b371ax1049x213.PNG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4f768264223140c0a149827bd6b2faad.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9424",
      "difficulty": "easy"
    },
    {
      "text": "A patient came with complaints of high-grade fever and altered sensorium. He was diagnosed to be suffering from meningococcal meningitis. Which of the following is the most appropriate empirical treatment option?",
      "choices": [
        {
          "id": 1,
          "text": "Penicillin G"
        },
        {
          "id": 2,
          "text": "Ceftriaxone"
        },
        {
          "id": 3,
          "text": "Cefotetan"
        },
        {
          "id": 4,
          "text": "Cefoxitin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Ceftriaxone </strong>or<strong> cefotaxime</strong>&nbsp;is the drug of choice for<strong> empirical treatment </strong>of <strong>meningococcal meningitis</strong><em>.</em>&nbsp;However,&nbsp;Penicillin G&nbsp;remains the&nbsp;antibiotic of choice for susceptible strains.</p>\n<p>Empirical antimicrobial therapy is initiated in patients with suspected bacterial meningitis before the results of CSF Gram stain and culture are known.</p>\n<p><strong><em>S. pneumoniae</em></strong> and <strong><em>N. meningitidis</em></strong> are the <strong>most common etiologic</strong> organisms of community-acquired bacterial meningitis.<strong>&nbsp;</strong>Due to the <strong>emergence of penicillin-resistant</strong> and cephalosporin-resistant <em>S. pneumoniae</em>, empirical therapy of community-acquired suspected bacterial meningitis should include a combination of:</p>\n<ul>\n<li>Dexamethasone</li>\n<li>Third- or fourth-generation cephalosporin (e.g., ceftriaxone, cefotaxime, or cefepime)</li>\n<li>Vancomycin</li>\n<li>Acyclovir&nbsp;- HSV encephalitis is the main differential</li>\n<li>Doxycycline -<strong>&nbsp;</strong>during tick season.</li>\n</ul>\n<p><strong>Ceftriaxone</strong> or <strong>cefotaxime</strong> provides better coverage for susceptible <em>S. pneumoniae</em>,&nbsp;<em>H. influenzae</em>&nbsp;and group B streptococci and good coverage for <em>N. meningitidis</em>. <strong>Cefepime</strong> is a broad-spectrum fourth-generation cephalosporin with activity similar to that of cefotaxime or ceftriaxone against <em>S. pneumoniae </em>and<em> N. meningitidis</em>&nbsp;with additional greater activity against Enterobacter species and <em>Pseudomonas aeruginosa</em>.</p><hr><h3>Related Pearl: Acute bacterial meningitis - causes and empirical treatment</h3><table>\n<tbody>\n<tr>\n<td><strong>Patient Group</strong></td>\n<td><strong>Bacterial Pathogen</strong></td>\n<td><strong>Empirical Therapy</strong></td>\n</tr>\n<tr>\n<td>Age&lt;1 month</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p>Enterobacteriacea</p>\n<p><em>Listeria monocytogenes</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br />Ampicillin</td>\n</tr>\n<tr>\n<td>1 month - 2 years</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p><em>H. influenza</em></p>\n<p><em>S. pneumonia</em></p>\n<p><em>N. meningitidis</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br />Ampicillin+<br />Vancomycin (if PRSP suspected)</td>\n</tr>\n<tr>\n<td>2 - 50 years and no risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br /><em>N. meningitidis</em><br /><br /></td>\n<td>\n<p>3rd generation cephalosporin+<br />Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Age &gt; 50 yrs and/or risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br /><em>N. meningitidis</em><br /><em>L. monocytogenes</em><br />Group B Streptococci</td>\n<td>\n<p>3rd generation cephalosporin+<br />Vancomycin+<br />Ampicillin</p>\n</td>\n</tr>\n<tr>\n<td>Post-craniotomy/Head trauma/CSF Rhinorrhea</td>\n<td>Gram negative bacilli</td>\n<td>\n<p>Ceftazidime+<br />Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Post-shunt surgery/ Ommaya reservoir</td>\n<td>\n<p><em>S. aureus</em><br />Coagulase-negative staphylococci</p>\n</td>\n<td>Ceftazidime+<br />Vancomycin</td>\n</tr>\n<tr>\n<td>Immunocompromised state </td>\n<td>\n<p><em> S. pneumoniae                    </em></p>\n<p><em>N. meningitidis                    </em></p>\n<p><em>L. monocytogenes       </em></p>\n<p>Gram negative bacilli </p>\n</td>\n<td>\n<p>Vancomycin+                      Ampicillin+                         Cefepime                           </p>\n<p>                   OR </p>\n<p>Vancomycin+                      Meropenem      </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*PRSP= penicillin-resistant S pneumoniae </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9428",
      "difficulty": "easy"
    },
    {
      "text": "A 60-year-old man post-MI had the following lab values. Which of the following must be his treatment plan?<div class='question-desc-html'><ul>\n<li>LDL - 125mg/dl</li>\n<li>HDL - 33 mg/dl</li>\n<li>TGL - 270mg/dl</li>\n</ul></div>",
      "choices": [
        {
          "id": 1,
          "text": "Rosuvastatin + fenofibrate"
        },
        {
          "id": 2,
          "text": "Atorvastatin 80 mg"
        },
        {
          "id": 3,
          "text": "Fenofibrate"
        },
        {
          "id": 4,
          "text": "Rosuvastatin 10 mg"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In this <strong>60 yr </strong>old patient with <strong>post-myocardial infarction</strong> (Atherosclerotic cardiovascular disease patient), <strong>high-intensity</strong> <strong>statins</strong> should be given <strong>irrespective of cholesterol levels</strong>. So <strong>atorvastatin 80mg</strong> is the treatment plan in the given case scenario.</p>\n<p>Examples of high-intensity statins include high-dose <strong>atorvastatin 40–80 mg/day</strong> and <strong>rosuvastatin 20–40 mg/day.</strong></p>\n<p>Note: Fenofibrate is not advocated unless TG is more than 500 mg/dl. It can be administered along with a moderate-intensity statin.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a664fd309c9e44d8bec9a2eaae5a64a5x1280x1803.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9429",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old smoker who is a known case of hypertension was on enalapril and hydrochlorothiazide. He had an episode of hemoptysis and on evaluation he was found to have bronchogenic carcinoma with brain metastasis. His lab values were Na -124 mg/dl, creatinine – 2.8 mg%, blood sugar 112 mg/dl, blood urea  - 24 mg/dl, serum osmolality – 255mosm, urine osmolality-350mosm, 24 hour urinary sodium 110 and BP-150/90 mmHg. Which of the following is the most probable diagnosis of the low sodium values in him",
      "choices": [
        {
          "id": 1,
          "text": "SIADH"
        },
        {
          "id": 2,
          "text": "Diuretic induced hyponatremia"
        },
        {
          "id": 3,
          "text": "Cerebral salt wasting syndrome"
        },
        {
          "id": 4,
          "text": "Pseudohyponatremia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario of patient who is a known hypertensive, smoker and bronchogenic carcinoma with brain metastasis having low sodium, low serum osmolality and high urine osmolality, the most probable diagnosis is of SIADH (<strong>S</strong>yndrome of<strong> I</strong>nappropriate secretion of <strong>ADH</strong>).</p>\n<p>From the given information, reduced serum osmolality rules out <strong>pseudohyponatremia</strong>(Option D) as such patients should be isotonic or have normal serum osmolality. The BP of the patient indicates there is no hypotension and patient is euvolemic, hence ruling out <strong>Cerebral Salt Wasting</strong> <strong>Syndrome</strong>(Option C) in which patient is hypovolemic and volume depleted.&nbsp; In <strong>thiazide induced SIADH</strong>(Option B), patients will be dehydrated and not euvolemic.&nbsp;&nbsp;</p>\n<p>In this patient, lung cancer and thiazides may cause SIADH.&nbsp;</p>\n<p><strong>Bartter and Schwartz diagnostic criteria of SIADH</strong></p>\n<ul>\n<li>Hyponatremia</li>\n<li>Clinically Euvolemic</li>\n<li>Serum osmolality less than 275 mOsm/Kg</li>\n<li>Urine Osmolality more than 100mOsm/Kg</li>\n<li>Urine sodium more than 40 mmol/L</li>\n<li>No use of diuretics</li>\n</ul>\n<p>In <strong>SIADH</strong>, if the hyponatremia is mild and asymptomatic, <strong>restrict</strong> total water intake to 30 mL/kg/day less than urine output until the syndrome resolves spontaneously. If the hyponatremia is severe and symptomatic, the goal is to partially correct it by intravenous infusion of <strong>hypertonic</strong> (3%) <strong>saline</strong> or administration of an <strong>AVP antagonist</strong> such as tolvaptan or conivaptan. With <strong>hypertonic saline</strong> or <strong>vaptans</strong>, plasma osmolarity and sodium should be checked every 1&ndash;2 h, and water intake should be adjusted to keep osmolarity 270 mosm/L, at which point the treatment should be discontinued.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8280",
      "difficulty": "medium"
    },
    {
      "text": "Non invasive test to detect hepatic fibrosis  include:",
      "choices": [
        {
          "id": 1,
          "text": "Aspartate aminotransferase/Platelet ratio"
        },
        {
          "id": 2,
          "text": "FibroTest"
        },
        {
          "id": 3,
          "text": "Forns index"
        },
        {
          "id": 4,
          "text": "Serum laminin and serum hyaluronidase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>FibroTest is a sensitive test to detect hepatic fibrosis. It is a multiparameter blood test which incorporates <strong>haptoglobin, bilirubin, GGT, apolipoprotein A-I, and&nbsp;</strong><strong>&alpha;2-macroglobulin</strong>.&nbsp;</p>\n<p>Aspartate aminotransferase/Platelet ratio and&nbsp;Forns index are tests to estimate the risk of developing liver fibrosis.</p>\n<p><strong>Fibrotest</strong> has high positive and negative predictive values for diagnosing <strong>advanced fibrosis</strong> in patients with alcoholic liver disease, chronic hepatitis B, chronic hepatitis C, nonalcoholic fatty liver disease and psoriasis patients taking methotrexate.</p>\n<p><strong>Transient elastography</strong> (TE) known as <strong>FibroScan</strong>, and <strong>magnetic resonance elastography</strong>(MRE) are used in patients of liver disease. TE is a <strong>noninvasive</strong> procedure uses ultrasound waves to measure hepatic stiffness and is accurate for identifying <strong>advanced fibrosis </strong>in patients with chronic hepatitis C, primary biliary cholangitis, hemochromatosis and nonalcoholic fatty liver disease. MRE is <strong>superior</strong> to TE for staging liver fibrosis in patients with a variety of chronic liver diseases but is expensive.</p>\n<p>Tests for estimating <strong>risk of developing hepatic fibrosis</strong>:</p>\n<ul>\n<li>AST/Platelet ratio</li>\n<li>Forns Index</li>\n<li>Fib-4</li>\n<li>Cirrhosis determinant score</li>\n</ul>\n<p>Test for <strong>detecting hepatic fibrosis</strong>:</p>\n<ul>\n<li>FibroTest (also called Fibrosure)</li>\n</ul>\n<p>Note:&nbsp;Serum laminin and serum hyaluronidase are non specific and is not preferred as a test to detect hepatic fibrosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8282",
      "difficulty": "medium"
    }
  ]
}